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Toxoplasma gondii is an important opportunistic protozoan parasite. Macrophages 
infected with Toxoplasma gondii cannot upregulate many pro-inflammatory cytokines, 
including tumor necrosis factor (TNF-α), upon stimulation with LPS and other Toll-
like receptor (TLR) ligands. However, LPS induction of IL-10 is not affected by the 
parasite. Here, we employed chromatin immunoprecipitation (ChIP) to examine TNF-
α promoter activity of infected macrophages. During LPS stimulation, Toxoplasma 
blocked recruitment of RNA polymerase II to the TNF-α promoter. In addition, 
binding of transcription factors NFκB, CREB and c-Jun was inhibited by infection. 
Analysis of chromatin structure surrounding the TNF promoter showed that LPS-
induced Ser10 phosphorylation and Lys9/14 acetylation of histone H3 (modifications 
associated with increased transcriptional activity) were inhibited by Toxoplasma. 
Immunofluorescence assays revealed that global Ser10 histone H3 phosphorylation 
levels were also blocked by T. gondii. Low level IL-10 gene induction by LPS that 
was not inhibited by the parasite did not require chromatin remodeling. However, high 
level IL-10 production induced by the combination of LPS and immune-complex (IC) 
stimulation was associated with histone H3 covalent modification. Remodeling of 
chromatin at the IL-10 promoter induced by LPS plus IC was also inhibited by 
Toxoplasma. Our results argue that Toxoplasma targets chromatin remodeling to 
inhibit cytokine gene transcription, and as such the data reveal a new mechanism by 
 which an intracellular pathogen incapacitates cytokine production during infection. 
We also performed further studies and obtained evidence that both MyD88 dependent 
and MyD88 independent TLR signaling were inhibited by the parasite. Strain 
comparison studies also showed that Type I parasite strains have the most potent 
inhibitory effects in interfering with host signaling.   
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1. Life cycle of Toxoplasma gondii 
Toxoplasma gondii is an intracellular apicomplexan protozoan parasite. It belongs to 
the phylum Apicomplexa and is the only species in genus Toxoplasma. It was 
originally identified in the small North African rodent Ctenodactylus gundi, hence its 
name (1). T. gondii is one of the most successful parasites with an approximate 
infection rate of 20-50% in the human population around the world. High infection has 
been related to a preference in consuming raw or undercooked meat and a climate 
favoring the survival of oocysts in certain countries (2). 
 
Members of the cat family (Felidae) are the only known definitive hosts for the sexual 
stages of T. gondii. Cats become infected with T. gondii by ingesting tissue cysts or 
oocysts from eating rats or mice. The parasites are then released from the cysts and 
invade epithelial cells of the small intestine where they undergo an asexual followed 
by a sexual cycle and form oocysts. Oocysts are excreted with cat feces. The 
unsporulated oocysts take 1 to 5 days after excretion to sporulate and become 
infective. Oocysts are resistant to disinfectants, freezing temperatures and drying 
conditions but are killed at 70°C
 
 for 10 minutes (3).  
Human and animal infections are naturally acquired by ingestion of undercooked meat 
containing Toxoplasma cysts or ingestion of the oocysts from fecally contaminated 
food (Figure 1.1). Organ transplantation or blood transfusion in humans also transmits 
the infection in certain conditions. Women who become infected during pregnancy 
can also transmit the parasite to the fetus. Within a normal immunocompetent host, 
replication of the parasites is suppressed and the parasites form tissue cysts, most 
commonly in skeletal muscle, myocardium, and central nerve system and normally 
remain quiescent throughout the life of the host (2). 
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Figure 1.1 Natural ways of Toxoplasma gondii infection. Cats are the only 
definitive host for the sexual stage of T. gondii. Wild rodents, including mice, as a 
major reservoir of infection, transmit the infection to cats during carnivorism. Oocysts 
are shed in the cat’s feces, allowing chances for infection of other species including 
human beings through accidental ingestion of oocyst contaminated water or food. 
Humans can also become infected by consuming undercooked meat containing 
parasite cysts.   
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2. Public health and T. gondii infection 
Infection by Toxoplasma is comprised of acute stages and chronic stages. The acute 
infection often incurs flu-like symptoms which fade within a few days to months, 
leading to the chronic stage when the replication of parasites is suppressed by the host 
immune system. During latent infection, the parasite forms tissue cysts found in 
skeletal muscle and central nervous system and thus remains quiescent (2).  
 
However, within immunosuppressed hosts, such as AIDS patients and organ transplant 
patients on immunosuppressive therapy, Toxoplasma is a dangerous opportunistic 
pathogen (4, 5). Reactivation of a persisting infection can result in life-threatening 
toxoplasmosis with encephalitis, necrotic lesions within the central nervous system 
(CNS) or retinochorioiditis. In the United States alone, between 10% and 40% of HIV-
infected patients are estimated to test positive for antibodies against T. gondii and 
some studies suggested that 24-47% of T gondii-seropositive AIDS patients eventually 
developed toxoplasmic encephalitis (6, 7). 
 
When a woman with no previous exposure to T. gondii becomes infected during 
pregnancy, the parasite can cross the placenta and infect the fetus. The premature 
immune system of the fetus cannot restrict the replication of the parasite within 
different fetal tissues, thus leading to hydrocephalus or microcephaly, intracranial 
calcification and chorioretinitis, with the possibility of spontaneous abortion or 
intrauterine death (8, 9).  
 
During the acute stage of infection, medications include antibiotic treatment with 
pyrimethamine, sulfadiazine, clindamycin and spiramycin. Pyrimethamine and 
sulfadiazine are used in combination to interfere with folic acid synthesis needed for 
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DNA and RNA synthesis in many species, including protozoan parasites. Clindamycin 
and spiramycin are used to interfere with protein synthesis of the parasite. In people 
with latent toxoplasmosis, the cysts become immune to these treatments. Medications 
that are prescribed include atovaquone and clindamycin for killing the cysts in AIDS 
patients. However, clearance of latent infection is very difficult and not guaranteed, as 
the antibiotics are hard to reach the bradyzoites in sufficient concentration (10). 
 
3. Biology of T. gondii 
T. gondii is a unicellular parasite that infects virtually any nucleated cell (11). The 
parasite structure is shown in Figure 1.2. During the cell invasion, the parasite first 
uses microneme proteins (MICs) to attach to the host through the binding of specific 
receptors (12, 13). Rhoptries, which are composed of a rhoptry neck and a rhoptry 
bulb, are then discharged. Rhoptries contain numerous enzymes that are released 
during the invasion process. A moving junction (MJ) is then assembled by the rhoptry 
neck proteins and microneme proteins to facilitate the movement of parasite, which 
helps the formation of the parasitophorous vacuole (PV) (14, 15). PV formation 
includes glycosylphosphatidylinositol (GPI)-anchored proteins, while excluding other 
host membrane proteins (14). Therefore, the PV is resistant to acidification and is non-
fusigenic with host lysosome (16, 17). Dense granule proteins are discharged after PV 
formation and form the intravacuolar network (IVN) of tubular membranes inside the 
PV (18, 19). Within the protective environment of PV, the parasite obtains nutrients 
by forming pores in the PVM that permit diffusion of small molecules (20). The 
parasite multiplies within the PV asexually by a specialized form of binary fission 
called endodyogeny and eventually lyses the host cell after 3 to 5 replication cycles of 
6 to 8 hours each (21, 22). The escape from the parasitophorous vacuole and host cell 
membrane requires both calcium and protease activity (23-26). More recently, egress 
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has been found to involve host cell calpain proteases where disruption of calpain 
activity by siRNA or genetic deletion prevented the egress of T. gondii from 
mammalian fibroblasts and genetic complementation restored the parasite egress (27).  
 
The natural populations of Toxoplasma in Europe and North America have been 
divided into three types by restriction fragment length polymorphism (RFLP) (28). 
They are found to have approximately 99% genetic identity. Only two separate alleles 
exist at any given locus of the three strains. This suggests that they are progenitors of a 
single cross between two parental strains (29). All three types are found in both 
humans and animals and they differ in virulence. Type I strains are the most virulent 
with a LD100 of a single parasite in the mouse model, while Type II and Type III 
strains are less virulent with LD100 of more than 1000 parasites. Therefore, only Type 
II and Type III strains establish stable chronic infection in mouse models and Type II 
strains are found to be the most common in human toxoplasmosis and chronically 
infected animals (30). Studies investigating virulence and pathogenicity showed that 
infection by Type I strains in mice results in more rapid dissemination of parasites 
throughout the body and higher tissue burden compared with other strains (31). The 
higher mobility and ability to penetrate across the intestinal epithelium of Type I 
strains may contribute to their high virulence (32). 
 
During infection, rhoptry proteins have been found to be important parasite effectors 
for manipulating host signaling pathways. ROP18 contains a kinase domain and 
displays a divergent expression profile between parasite strains (33). ROP18 lacks 
expression in Type III strains probably because an extra 2.1kb sequence exists near the 
start codon in Type III strains (34). Studies found that when ROP18 from a Type I 
strain is expressed in a Type III strain, the parasite gains a much higher intracellular 
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Figure 1.2 Structure of Toxoplasma gondii. Toxoplasma contains three secretory 
organelles: micronemes, rhoptries and dense granules. During cell attachment and 
invasion, micronemes are first discharged followed by rhoptries. Dense granules are 
released after parasite invades the cell.   
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replication rate and a higher virulence causing rapid death of infected mice (35). In 
natural isolates, ROP18 expression level directly correlates with virulence and 
intracelluar growth rate. However, a host protein substrate has not yet been identified 
while a 70-kDa protein from a tachyzoite lysate is found to be phosphorylated by 
ROP18 (33). This suggests that ROP18 acts on the parasite itself.     
 
Another rhoptry protein, ROP16, also has a kinase domain but is found to be more 
related with modulation of host signaling. The rapid and sustained STAT3 tyrosine 
phosphorylation triggered by T. gondii infection requires ROP16 even though ROP16 
seems to act indirectly because it is a putative serine/threonine kinase (36). ROP16 
contains a nuclear localization signal and accumulates within the host nucleus soon 
after infection, suggesting that it is acting on some yet to be indentified host molecule. 
Type II parasites lack ROP16 and this likely contributes to low virulence of Type II 
since STAT3 phosphorylation is not sustained upon infection, and a high level of IL-
12 production is induced, which helps maintain the survival of both host and Type II 
parasite (34, 37).   
 
4. Toxoplasma and host immunity 
The major cell type studied in my thesis are macrophages because they are readily 
infected by Toxoplasma and used by the parasite as reservoirs of infection and early 
dissemination. Macrophages are an important component of the innate immune system 
and play a key role in defense against infection. These cells are poised to respond to 
microbial antigens and possibly host 'danger' signals that sense presence of infection. 
Macrophages are located throughout tissues and their precursors circulate in the blood 
as undifferentiated monocytes. They probably participate in first encounter with 
invading microbial pathogens, yet they also serve as targets of infection for many 
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intracellular microorganisms (38, 39). Therefore, complex biological relationships 
probably occur between macrophages and intracellular pathogens that reside within 
these cells.  
 
Macrophages are armed with multiple effector functions. They are potent phagocytes 
that may rapidly degrade the microorganisms. Nitric oxide production is another 
macrophage antimicrobial defence mechanism. Cells can upregulate the enzyme 
inducible nitric oxide synthase (iNOS) leading to high level production of nitric oxide. 
This short-lived, but highly reactive, molecule interferes with multiple metabolic 
pathways required for microbial survival. Similar to nitric oxide production, 
macrophages can undergo an oxygen-dependent respiratory burst during infection, 
which kills microorganisms through generation of toxic intermediates such as 
superoxide and hypochlorate. Microbial products, especially bacterial endotoxin such 
as LPS, can activate macrophages and elicit high level antimicrobial activity and 
cytokine production (40, 41). 
 
Macrophages are also important in bridging innate and acquired immunity. They are 
capable of producing high amounts of IL-12 and presenting antigenic peptides with 
MHC and co-stimulatory molecules such as CD80/CD86. The polarizing signal (IL-
12), antigen triggering, and co-stimulation comprise three signals necessary to drive 
Th1-type acquired immunity (42). Thus, macrophages may also be important in 
triggering the Th1 response that is crucial to control microbial infection. 
 
Upon infection, T. gondii elicits an early IL-12 response from innate immune cells 
such as DC, macrophages and neutrophils. This IL-12 response is critical in the 
control of infection in that it promotes activation of Th1 T cells, NK cells and CD8 T 
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cells which produce IFNγ. IFNγ is the major effector molecule in limiting infection 
during both acute and chronic stages. It mediates its protective function through 
STAT1, which generates nitric oxide, and induces IGTP and LRG-47 to kill the 
intracellular parasite (Figure 1.3) (43, 44). It has been shown that absence of IL-12, 
IFNγ or T cells leads to rapid death during Toxoplasma infection in mouse models 
(45-47). Mice deficient in the iNOS gene are more susceptible to T. gondii infection 
(47). The IFNγ responsive genes, such as IGTP and LRG-47 are also essential in 
surviving acute infection as both IGTP and LRG-47 knockout (KO) mice succumb 
with similar kinetics as IFNγ and IL-12 deficient mice (48, 49).   
 
In order to establish long term infection, Toxoplasma needs to avoid elimination from 
the host while eliciting an immune response to keep the host alive. Also, an immune 
response too vigorous can lead to lethal immunopathology. Overproduction of 
cytokines such as IL-12, TNFα and IFNγ leads to the death in IL-10 KO mice during 
non-lethal infection (50-52). C57BL/6 mice are susceptible to oral infection largely 
due to severe gut pathology mediated by CD4+ T cells and IFNγ (53). In this regard, 
in vitro studies showed that Toxoplasma actively suppresses proinflammatory 
responses during intracellular infection, a response that might enable self survival and 
replication and avoid immunopathologic damage to the host. Infected macrophages do 
not produce TNFα, and the IL-12 response is only induced after approximately 24 hrs. 
The cells also lose the ability to respond to LPS stimulation. Inhibition is specific to 
infected cells and requires active invasion by the parasite (54, 55).  
 
Interference with mitogen-activated protein kinase (MAPK) activation, NFκB nuclear 
translocation, and activation of STAT3 have been implicated in the inhibition by the 
parasite. Specifically, Toxoplasma infected cells display defects in LPS-induced  
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Figure 1.3 T. gondii and host immunity. Upon infection, the innate immune system 
first reacts to the parasite. Macrophages, DCs and PMNs produce IL-12, which 
activates NK cells, CD4+ T cells and CD8+ cells. These cells produce IFN-γ. IFN-γ 
mediates anti-Toxoplasma effects by inducing iNOS, IGTP and LRG-47. It also 
potentiates the innate immune system by activating the killing mechanisms of 
macrophages. 
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MAPK phosphorylation and NFκB nuclear translocation (56). Cell invasion by 
Toxoplasma also induces rapid and sustained activation of host STAT3. This mediates 
inhibition of IL-12 and TNFα as Toxoplasma is not able to suppress the cytokine 
production in the absence of STAT3 (57). 
 
Studies comparing T. gondii Type I and Type II strains showed that there are strain 
differences in parasite elicited MAPK activation and IL-12 production. The Type I RH 
strain triggers MAPK activation and IL-12 production in a MyD88-dependent 
pathway, while induction of IL-12 by the Type II ME49 strain involves both MyD88-
dependent and MyD88-independent pathways (58).  IL-12 production by parasite 
infected macrophages is generally higher when the cells are infected with Type II 
strains (37).  
 
During chronic infection, Toxoplasma preferentially forms cysts in the brain. A 
balance of host immune responses and the parasite’s evasion of such responses must 
be established to maintain this chronic stage of infection. IFN-γ has been found to be 
essential to control the infection in the brain. A variety of cytokines are induced by 
infection from microglia, astrocytes, and neurons, 
 
which either promote or suppress 
inflammatory responses (59-61). A delicate interplay between the host and the parasite 
maintains the chronic infection. The parasite strain, host genotype and route of 
infection are all involved in this interplay. 
Most of our studies examined the effects of parasite infection on macrophage 
signaling after overnight infection followed by LPS stimulation. This is biologically 
relevant because natural infection leads to damage of small intestine and leakage of 
bacterial products such as LPS. Macrophages that are recruited by the infection are 
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then encountering stimulants coming from bacteria.  Therefore, our studies mimic the 
natural in vivo situation upon infection.  
 
5. Toll-like receptors and Toxoplasma 
Toll-like receptors (TLR) play an essential role in sensing and responding to 
pathogens by the innate immune system (62, 63). Signalling through TLR leads to 
induction of proinflammatory cytokines and chemokines, as well as anti-microbial 
molecules such as nitric oxide generated by inducible nitric oxide synthase. To date, 
11–13 TLR molecules have been identified in mammals. Most are expressed on the 
cell surface, but some are expressed in intracellular compartments (TLR3, 7, 8 and 9) 
(64). One of the best characterized is TLR4, which, along with MD2, serves as a 
receptor for Gram-negative bacterial LPS. With the exception of TLR3, activation 
through these receptors requires recruitment of adaptor molecule MyD88, in turn 
resulting in recruitment of IL-1 receptor-associated kinases 1 and 4. These molecules 
form a complex with TNF receptor-associated factor (TRAF) 6, resulting in 
interaction with Uva1 and Ubc13, leading in turn to ubiquitination of TRAF6. Then, 
ubiquitinated TRAF6 activates transforming growth factor-β-activated kinase (TAK) 1. 
Interacting with TAK1-binding proteins 1 and 2, TAK1 serves as a mitogen-activated 
kinase kinase kinase, triggering the MAPK cascade. The TAK1 molecule also 
activates the IκB kinase complex. This results in phosphorylation-dependent 
ubiquitination and degradation of IκBα, enabling nuclear translocation of NFκB (63). 
 
Studies showed that both NFκB and MAPK pathways downstream of TLR signaling 
are inhibited by T. gondii infection even though the parasite increases TLR4 
expression. During early infection of macrophages, the parasite is found to block 
nuclear translocation of NFκB in response to LPS despite the fact that IκBα undergoes 
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normal degradation (54, 56, 65). When the cells are stimulated with LPS 6 hr or more 
after infection, nuclear translocation of NFκB is restored, indicating that the inhibitory 
effect on NFκB is transient (56). Infected cells also display impaired MAPK activation 
triggered by LPS, particularly p38 MAPK, which is required for LPS-triggered TNFα 
and IL-12 production. This is not due to defective upstream signaling as the kinase for 
p38, MAPK kinase 3/6, is activated and remains so upon infection (56). 
Nonresponsiveness of infected macrophages to LPS restimulation resembles LPS 
tolerance in some aspects. However, a study comparing the two processes found them 
to be distinct. Parasite infection induces sustained activation of the MAPK kinase 
MKK3/6. In contrast, during LPS stimulation of LPS-tolerized cells, phosphorylation 
of MKK3/6 is defective. Futhermore, IκBα is resistant to TLR4-induced degradation in 
LPS-tolerized macrophages, whereas in T. gondii infected cells this molecule 
undergoes normal degradation following LPS exposure (66). It is currently not clear 
whether Toxoplasma blocks activation of MAPK through the activity of host or 
parasite phosphatases, or by other phosphatase-independent mechanisms.  
 
 
There is also evidence that type II T. gondii strains themselves induce NFκB activation, 
and as mentioned previously, IL-12 production induced by the type II ME49 strain is 
partially dependent upon MyD88 (37, 67). Toxoplasma itself also mediates a rapid but 
transient activation of MAPK pathways including SAPK/JNK, p38 and ERK1/2 
during macrophage infection and p38 and SAPK/JNK MAPK activation contributes to 
parasite induced IL-12 production (68, 69). However, as mentioned above, subsequent 
stimulation with LPS fails to result in robust activation normally associated with TLR 
stimulation.  
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Toxoplasma tachyzoite glycosylphosphatidylinositol lipid anchors activate TLR2 and 
TLR4. Also, T. gondii profilin induces high level TLR11-dependent IL-12 production 
in mouse DCs, although this TLR molecule is not expressed in humans (70).  
 
Studies performed on mice deficient in TLR signaling pathways revealed their 
importance in survival of T. gondii infection. MyD88-/- mice succumb to infection 
while mice defective in production of IL-1 and IL-18 resist infection normally (71, 72). 
This indicates the unique importance of TLR signaling since IL-1 and IL-18 signaling 
also involves MyD88. TLR2-/-
 
 mice displayed increased susceptibility to high dose 
Toxoplasma infection (73). However, upon low-dose infection, knock out of either 
TLR-2 or TLR-4 had no effect in survival. Genetic deletion of both TLR2 and TLR4 
did lead to an increase in cyst burden (74). This suggests that there is some functional 
redundancy between TLR2 and TLR4.  Mice deficient in TLR11 had increased brain 
cyst numbers but still survived (75).  
6. Histone modification and chromatin remodeling 
A large part of my thesis focuses on histone modification in Toxoplasma infected cells. 
Inducible gene expression is now understood to involve two types of regulatory 
cascades. One type of transduction cascade leads to transcription factor activation, 
most often involving kinase signalling, to enable binding to target DNA sites on gene 
promoters. The particular pattern of transcription factors activated plays a role in 
determining the specificity of genes induced. At the same time, it is now appreciated 
that chromatin structure itself is subject to regulation, inasmuch as signalling leading 
to covalent modification of histones plays a role in determining the activity of 
transcription factors (Figure 1.4) (76, 77). 
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Histones undergo posttranslational modifications which alter their interaction with 
DNA and nuclear proteins. The H3 and H4 histones have long N-terminal tails 
protruding from the nucleosome which can be covalently modified at several places. 
Modifications of the tail include methylation, acetylation, phosphorylation, 
ubiquitination, sumoylation, citrullination, and ADP ribosylation. The core of the 
histones (H2A and H3) can also be modified. Combinations of modifications are 
thought to constitute a code, the so-called "histone code". Histone modifications act in 
diverse biological processes such as gene regulation, DNA repair and chromosome 
condensation (mitosis) (78). 
 
DNA methylation and histone post-translational modifications lead to the recruitment 
of protein complexes that both positively and negatively regulate transcription. All 
histone post transcriptional modifications are reversible. Histone deacetylases 
(HDACs) remove acetyl groups and Ser/Thr phosphatases remove phosphate groups. 
Ubiquitin proteases remove mono-ubiquitin from H2B. Arginine methylation is 
altered by deiminases, which convert the side chain to citrulline . The functional 
consequences of histone post transcriptional modifications can be direct, causing 
structural changes to chromatin, or indirect, acting through the recruitment of effector 
proteins (79).  
 
Acetylation of the lysine residues at the N terminus of histone proteins removes 
positive charges, thereby reducing the affinity between histones and DNA.  This 
makes it easier for RNA polymerase and transcription factors to access the promoter 
region.  Therefore, in most cases, histone acetylation enhances transcription while 
histone deacetylation represses transcription. Histone acetylation is catalyzed by 
histone acetyltransferases (HATs) and histone deacetylation is catalyzed by histone 
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deacetylases (denoted by HDs or HDACs).  Several different forms of HATs and HDs 
have been identified.  Among them, CBP/p300 is probably the most important, since it 
can interact with numerous transcription regulators (80, 81).  
 
Phosphorylation of serine 10 in histone H3 has been shown to correlate with gene 
activation in mammalian cells and with the induction of transcription during heat-
shock response in Drosophila. Quiescent fibroblasts treated with epidermal growth 
factor undergo rapid serine 10 phosphorylation, coincident with the induction of early 
response genes such as c-fos (82). This phosphorylation is catalyzed by MSK-1 and 
MSK-2, two kinases downstream of p38 and ERK MAPKs (83).  
 
In mammalian cells, H3 phosphorylation is mediated via the ERK or p38 MAP kinase 
pathways depending on the stimulus used, but not the JNK/SAPK pathway (84, 85). It 
is known that inflammatory signals induce p38 mitogen-activated protein 
kinase−dependent phosphorylation and phosphoacetylation of histone H3, which 
selectively occurred on the promoters of a subset of stimulus-induced cytokine and 
chemokine genes. p38 activity was shown to be required to enhance the accessibility 
of the cryptic NFκB binding sites within H3 phosphorylated promoters (86-89). This 
indicates that p38-dependent H3 phosphorylation may mark promoters for increased 
NFκB recruitment. The regulation of histone H3 phosphorylation at Ser10 is therefore 
of special interest. Two kinases downstream of p38 and ERK MAPK, MSK-1 and 
MSK-2 have been suggested to directly phosphorylate histone H3 when the cell is 
treated with a mitogen signal or exposed to stresses (83, 90). More recently, histone 
H3 has been found to be a novel substrate for MAP Kinase Phosphatase-1 (MKP-1) 
which normally dephosphorylates MAP kinases (91, 92). 
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Figure 1.4 Chromatin structure and gene transcription. Under silent condition, the 
gene promoter region remains condensed, DNA remains methylated, and histone tails 
remain suppressively modified. Transcription factors can not bind to the promoter 
region and transcription is not initiated in this case. Upon activation signal, histone 
tails undergo modifications that opens up the chromatin structure. DNA becomes 
unmethylated. Transcriptional machinery binds to the promoter and starts gene 
transcription. 
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7. Brief outline of dissertation research 
Toxoplasma infection inhibits LPS-triggered IL-12 and TNFα production in 
macrophages. After about 12 hr post infection, the block in IL-12 production is lifted 
and the parasite itself induces IL-12. However, TNFα production remains potently 
suppressed. The molecular mechanism of TNFα inhibition in macrophages is not yet 
understood. Chapter 2 reports that Toxoplasma prevents the binding of transcription 
factors such as NFκB, c-Jun and CREB to the TNFα promoter region by interfering 
with histone modifications on both distal and proximal regions. Specifically, the 
parasite blocks the phosphorylation of histone H3 at Ser 10 and acetylation of histone 
H3 at Lys9/Lys14 triggered by LPS. These findings led to the study in Chapter 3 
where I found that Toxoplasma inhibits production of high level IL-10 induced by 
immune complex in the presence of LPS in macrophages through a similar mechansim 
where the histone modifications required for transcription initiation is blocked by the 
parasite. Chapter 4 describes experiments showing that Toxoplasma is able to block 
different TLR ligand induced IL-12 responses in macrophages. Moreover, the parasite 
also inhibits type I interferon production triggered by MyD88-independent TLR-3 
signaling. Parasite strain comparison studies show that only Type I RH strain inhibits 
TNFα in dendritic cells and RH strain most potently blocks LPS-induced 
phosphorylation of histone H3 at Serine 10 compared with Type II and Type III strains. 
Finally, Chapter 5 summarizes the results in this thesis and discusses the significance 
of the above findings. 
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CHAPTER TWO 
 
Toxoplasma gondii Prevents Chromatin Remodeling 
Initiated by Toll-Like Receptor-Triggered 
Macrophage Activation* 
 
 
 
 
 
 
 
 
 
 
 
 
*This Chapter is reprinted from “Toxoplasma gondii prevents chromatin remodeling 
initiated by TLR-triggered macrophage activation” by J. Leng, B. A. Butcher, C. E. 
Egan, D. S. Abdallah, E. Y. Denkers. The Journal of Immunology, 2009 Jan 
1;182(1):489-97.  
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ABSTRACT 
Macrophages infected with the opportunistic protozoan Toxoplasma gondii are unable 
to upregulate many pro-inflammatory cytokine genes, including tumor necrosis factor 
(TNF-α), upon stimulation with LPS and other Toll-like receptor (TLR) ligands. Here, 
we examined the influence of T. gondii on transcription factors associated with TNF-α 
transcription, as well as phosphorylation and acetylation of histone H3 at distal and 
proximal regions of the TNF-α promoter. During LPS stimulation, we found that 
Toxoplasma blocks nuclear accumulation of transcription factor c-Jun, but not that of 
CRE binding protein (CREB) or NFκB. However, chromatin immunoprecipitation 
studies revealed that binding of all these transcription factors to the TNF promoter was 
decreased by T. gondii infection. Furthermore, the parasite blocked LPS-induced Ser10 
phosphorylation and Lys9/Lys14
 
 acetylation of histone H3 molecules associated with 
distal and proximal regions of the TNF-α promoter. Our results show that Toxoplasma 
inhibits TNF-α transcription by interfering with chromatin remodeling events required 
for transcriptional activation at the TNF promoter, revealing a new mechanism by 
which a eukaryotic pathogen incapacitates proinflammatory cytokine production 
during infection.  
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INTRODUCTION 
The opportunistic intracellular protozoan Toxoplasma gondii is a potent trigger of Th1 
cytokines, a response that enables host survival and long-term parasite persistence (1, 
2). Proinflammatory cytokine induction must be tightly regulated, because when 
overproduced these mediators cause immunopathology and host death. For T. gondii, 
this is exemplified during infection of IL-10 knockout mice that succumb from an 
inability to down-regulate parasite-induced proinflammatory cytokine production (3). 
From the perspective of the parasite, preventing overinduction of cytokines such as 
TNF-α, IL-12 and IFN-γ has the dual benefit of keeping the host alive to allow 
persistence while avoiding immune-mediated elimination.    
 
In recent years, it has become clear that Toxoplasma takes an active role in interfering 
with intracellular signaling leading to proinflammatory mediators including IL-12, 
TNF-α, and nitric oxide (4-8). The exact molecular mechanisms by which this occurs 
remain largely unknown, although interference with mitogen-activated protein kinase 
(MAPK) activation, NFκB translocation as well as activation signal transducer and 
activator of transcription (STAT)-3 has been implicated (4, 9-13). In our studies, we 
have focused on T. gondii-infected macrophages, where a large panel of LPS-
responsive genes, including IL-12p40 and TNF-α, is suppressed (5). For the case of 
IL-12, inhibition is relieved after approximately 12 hr, but TNF-α remains potently 
suppressed throughout the time course of infection (14). Because of the dramatic 
effect of Toxoplasma on macrophage TNF-α production, we chose to focus in detail on 
induction of this mediator to gain insight into how the parasite interferes with host cell 
signaling. 
 
Regulation of TNF-α production is complex, and is controlled in a tissue-specific and 
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stimulus-specific manner (15-17). The primary control step of TNF-α gene expression 
resides in transcription initiation (18, 19). Studies have established that NFAT, ATF-2, 
Jun, Ets/Elk, and Sp-1 transcription factors and CBP/p300 coactivator proteins are 
involved in regulation of TNF-α transcription (16, 19). NFκB binding to distal κB sites 
is also important for maximal induction of TNF-α (20). Downstream of these events, 
production of TNF-α protein is also dependent upon regulation of mRNA splicing, 
regulation of mRNA half-life, and regulation of mRNA translation (21, 22).  
 
Transcriptional initiation of many genes, including TNF-α, requires changes in higher 
order chromatin structure surrounding the promoter (23-25). In general, the promoter 
region undergoes stimulus-induced chromatin remodeling to allow access of 
transcription factors and RNA polymerase II machinery. Chromatin remodeling 
usually includes histone phosphorylation, acetylation and methylation, accompanied 
by nucleosome disassembly (26). The particular pattern of modification, also known 
as the histone code, determines whether a gene is in an active or inactive conformation 
(27). Among the histone modifications, phosphorylation of histone H3 at serine 10, 
acetylation of histone H3 at lysines 9 and 14, and methylation of histone H3 at lysine 4 
are associated with gene activation.  
 
Here, we show that macrophage infection by T. gondii inhibits recruitment of RNA 
polymerase II to the TNF-α promoter during LPS stimulation. Focusing on TNF-
associated transcription factors, we found that nuclear accumulation of c-Jun, but not 
NFκB p65 or cAMP-responsive element-binding protein (CREB), was blocked by the 
parasite. Despite LPS induction of nuclear NFκB and CREB in infected cells, the 
parasite prevented recruitment of each to their respective sites on the TNF promoter. 
Furthermore, Toxoplasma interfered with LPS-induced histone H3 phosphorylation 
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and acetylation surrounding the TNF-α promoter, providing an explanation for the 
inability to recruit transcription factors and RNA polymerase II. These results show 
that T. gondii targets the histone modification machinery to prevent TNF-α 
transcription, and they provide a likely explanation for the widespread suppressive 
effects of the parasite on proinflammatory genes induced by LPS and possibly other 
stimuli.    
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MATERIALS AND METHODS 
Mice and Parasites 
C57BL/6 female mice (6-8 wk of age) were purchased from The Jackson Laboratory. 
The mice were kept under specific pathogen-free conditions at the Transgenic Mouse 
Facility, Cornell University College of Veterinary Medicine. The facility is overseen 
by an Institutional Animal Care and Use committee. T. gondii parasite strains RH, CC, 
ENT and DEG were maintained by biweekly passage on human foreskin fibroblast 
monolayers in DMEM supplemented with 1% FCS, 100 U/ml penicillin and 0.1 
mg/ml streptomycin. In some experiments, we employed transgenic RH strain 
tachyzoites expressing tandem copies of the gene encoding yellow fluorescent protein 
(kindly provided by D. Roos and B. Striepen). Parasite cultures were tested for 
Mycoplasma every 6-8 wk using a highly sensitive PCR-based ELISA (Roche 
Diagnostics).  
 
Cell Culture 
Bone marrow cells were flushed from femur and tibia and cultured in cDMEM 
consisting of DMEM supplemented with 10% FCS, 1 mM sodium pyruvate, 0.1 mM 
nonessential amino acids, 20% supernatant from L929 cells, 100 U/ml penicillin and 
0.1 mg/ml streptomycin. The cells were supplemented with fresh macrophage medium 
on Day 3. After 5 days of culture, nonadherent cells were removed, adherent 
monolayers were washed in ice-cold PBS, and cells were harvested by gentle pipetting 
in DMEM supplemented with 1% FCS, 100 U/ml penicillin and 0.1 mg/ml 
streptomycin. Infection of macrophages was accomplished by adding tachyzoites to 
cell cultures followed by brief centrifugation (200 x g for 3 min) to synchronize 
contact between cells and parasites. In most cases, LPS (100 ng/ml) was added 12 hr 
after infection. Cells were recovered at varying times as indicated, depending upon the 
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assay performed.  
 
Semi-Quantitative Real-time PCR 
Real-time PCR were performed with a Power SYBR green kit according to the 
manufacturer’s instructions (Cat. 4367659, Applied Biosystems). The primers 
employed were as follows. TNF RNA pol II site 1 forward: 
GAAAAGCAAGCAGCCAACCA; TNF RNA pol II site 1 reverse: 
CGGATCATGCTTTCTGTGCTC; TNF RNA pol II site 2 forward: 
ACAGAAAGCATGATCCGCGA; TNF RNA pol II site 2 reverse: 
GCCACAAGCAGGAATGAGAAGA; TNF forward: 
CCTTGTTGCCTCCTCTTTTGC; TNF reverse: TCAGTGATGTAGCGACAGCCTG; 
IL-10 forward: CCTGGCTCAGCACTGCTAT; IL-10 reverse: 
GCTCTTATTTTCACAGGGGAGAA; TNF promoter proximal forward: 
CCCCAACTTTCCAAACCCTCT; TNF promoter proximal reverse: 
CCCTCGGAAAACTTCCTTGGT; TNF promoter distal forward: 
GGCTTGTGAGGTCCGTGAATT; TNF promoter distal reverse: 
CCCTCGGAAAACTTCCTTGGT; IL-10 promoter forward: 
GCAGAAGTTCATTCCGACCA; IL-10 promoter reverse: GGCTCCTCCTCC 
CTCTTCTA; GAPDH forward: CCTGAACAGAACAGCAATGGCT; GAPDH 
reverse: GCTTGACGGTGTCTTTTGCCT. 
 
Cytokine ELISA 
IL-10 and TNF-α in cell cultures were measured using commercial kits according to 
the manufacturer’s recommendations (R and D Systems). 
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Immunoblotting 
The following antibodies were employed in immunoblotting studies: anti-phospho-c-
Jun (cat. # 2361, Cell Signaling), anti-total-c-Jun (cat. # 9165, Cell Signaling), anti-
phospho-CREB (cat. # 9191, Cell Signaling), anti-total CREB (cat. # 9197, Cell 
Signaling), anti-PARP (cat. # 9542, Cell Signaling), anti-NFκB p65 (cat. # SC-109, 
Santa Cruz Biotechnology), anti-phospho-histone H3 (Ser10) (cat. # 9701, Cell 
Signaling), anti-acetyl-histone H3 (Lys9/14) (cat. # 9677, Cell Signaling), anti-total H3 
(cat. # 9715, Cell Signaling) and anti-phospho-MSK1 (cat. # 9591, Cell Signaling). 
Cells (2 x 106/sample) were lysed in reducing SDS sample buffer, and DNA was 
sheared by forcing samples 5 times through a 27-gauge needle. In some experiments, 
nuclear and cytoplasmic portions of cell lysates were separated by using a nuclear 
extract kit (Active Motif). After 5 min at 100ºC, samples were separated by 10% SDS-
PAGE, and proteins were subsequently electrotransferred onto nitrocellulose 
membranes. Membranes were then blocked in 5% nonfat dry milk containing 0.1% 
Tween 20 in Tris-buffered saline, pH 7.6 (TBST), for 1 hr at room 
temperature, followed by incubation with antibody reconstituted in 5% BSA in TBST 
overnight at 4°C. After washing blots in TBST, primary antibodies were detected 
with a horseradish peroxidase-conjugated secondary antibody in TBST containing 5% 
nonfat dry milk for 1 h at room temperature. 
 
After washing in TBST, protein bands 
were visualized using a chemiluminescence based detection system (Cell Signaling). 
Chromatin Immunoprecipitation (ChIP) 
The following ChIP grade antibodies were employed for immunoprecipitation: anti-
RNA pol II (cat. # 39097, Active Motif), anti-NFκB p65 (cat. # SC-109, Santa Cruz 
Biotechnology), anti-phospho-CREB (cat. # 9197, Cell Signaling), anti-phospho-c-Jun 
(cat. # 2361, Cell Signaling), anti-phospho-histone H3 (Ser10) (cat. # 9701, Cell 
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Signaling), anti-acetyl-histone H3 (Lys9/Lys14) (cat. # 9677, Cell Signaling). Assays 
were performed using the ChIP-IT enzymatic express kit (Active Motif) according to 
the manufacturer’s instructions. Briefly, cells (1.5 x 107/sample) were fixed using 1% 
formaldehyde at room temperature for 10 min. Fixation was stopped by adding glycine 
to the mixture. The cells were then collected by scraping in buffer containing PMSF 
(100 mM). After brief centrifugation, the cells were resuspended in lysis buffer 
(Active Motif) with a protease inhibitor cocktail (Active Motif) and incubated for 30 
min on ice. The cells were then resuspended in cell digestion buffer (Active Motif) 
and subjected to enzymatic digestion for 10 min at 37ºC. The reaction was stopped 
with addition of 0.5 M EDTA. Antibodies were added into the sheared chromatin 
preparations and the mixture was incubated with Protein G Magnetic Beads (Active 
Motif) overnight at 4ºC. The precipitated DNA-protein-antibody complexes were then 
washed and the crosslinking was reversed by incubation at 65ºC for 4 hr. Proteinase K 
was added to digest protein and DNA subsequently was purified using ethanol 
extraction, air dried and redissolved in 100 µl H2
 
O. The retrieved DNA was then 
subjected to real-time RT-PCR amplification using promoter-specific primers. 
Transcription Factor DNA-binding ELISA 
Presence of NFκB p65 in nuclear extracts was determined by binding to plate-bound 
target oligonucleotides exactly according to the manufacturer’s instructions (Active 
Motif).  
  
Immunofluorescence Microscopy 
Macrophages were plated onto coverslips and infected with RH strain tachyzoites at a 
parasite to cell ratio of 4: 1. After overnight incubation, cells were treated with LPS 
(100 ng/ml) for 30-60 min. Coverslips bearing macrophages were fixed with 3% PFA 
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(20 min, room temperature) then permeabilized with methanol for 10 min at -20ºC. 
Coverslips were blocked with 5% normal goat serum in PBST for 60 min, then rabbit 
anti-phospho-H3 (Ser 10) antibody (cat. # 9701, Cell Signaling) or rabbit anti-acetyl-
histone H3 (Lys9/14
 
) (cat. # 9677, Cell Signaling) was added in PBST to the coverslips, 
and cells were incubated overnight at 4ºC. Coverslips were washed with PBS then 
goat anti-rabbit antibody conjugated to Alexa Fluor 594 and anti-Toxoplasma p30 
conjugated to FITC was added and cell were incubated 2 hr at 4ºC. After washing in 
PBS, coverslips were mounted with ProLong Antifade containing DAPI (Molecular 
Probes). Images were collected with a BX51 fluorescence microscope (Olympus) 
equipped with a DP 70 camera using DP controller software (Ver.1.1.1.65, Olympus) 
and DP manager software (Ver.1.1.1.71, Olympus). 
Flow Cytometry 
Peritoneal cells from infected mice were washed in cDMEM, resuspended at 1 x 
107/ml and plated in a 24-well plate. Brefeldin A (Golgi plug, BD Biosciences) was 
added into the culture to block the protein transport. The cells were then stimulated 
with LPS. After 6 hours of incubation, the cells were washed in FACS wash buffer (1% 
BSA in PBS) and plated 2 x 106 per well in 96-well plate. F4/80 APC antibody (cat. # 
MF48005, Caltag Laboratories) was added and incubated for 20 min at 4ºC. The cells 
were then washed twice with FACS wash buffer and incubated with 200 µl 
Fix/Permeabilization buffer (BD Biosciences) for 15 min. The cells were washed 
again and resuspended in antibody cocktail containing anti-TNF PE (cat. # 554419, 
BD Biosciences) and anti-p30 FITC (cat. # 12-132, Argene). After 1 hr of incubation, 
cells were washed and resuspended in FACS wash buffer. Samples were analyzed on a 
FACScalibur flow cytometer (BD Biosciences) collecting at least 50,000 events. The 
data were subsequently analyzed using FlowJo software (Tree Star). 
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Statistics 
The statistical significance of the data was determined by unpaired Student’s t test. 
Values of p < 0.05 were considered significant. All experiments were performed at 
least three times. 
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RESULTS 
T. gondii potently and specifically inhibits TLR-induced TNF-α production in 
macrophages  
Previously we established that T. gondii infection inhibits LPS induced production of 
TNF and other proinflammatory mediators in mouse macrophages (5, 14). In order to 
confirm and extend these results, we employed the type I T. gondii RH strain to infect 
bone marrow-derived macrophages, cells that are readily invaded by the parasite (Fig. 
2.1A and B). When infected cells were subjected to LPS/TLR4 triggering, TNF-α 
cytokine release was potently suppressed (Fig. 2.1C). Parasite-induced suppression of 
TNF-α was maintained for up to 36 hr post-LPS stimulation (data not shown). This 
was not a nonspecific cytotoxic effect, because LPS-induced IL-10 production was 
unaffected by parasite infection (Fig. 2.1D). We also examined cytokine mRNA levels 
during LPS stimulation of infected cells. In accord with the cytokine protein data, 
LPS-induced TNF mRNA induction was inhibited by pre-infection with T. gondii (Fig. 
2.1E). In contrast, there was no consistent effect of the parasite on IL-10 mRNA 
during LPS stimulation (Fig. 2.1F).   
 
T. gondii inhibits TNF-α induction by multiple TLR ligands and multiple parasite 
strains interfere with TNF-α induction  
To examine whether T. gondii blocks TNF release triggered through other TLR 
pathways in addition to that initiated by LPS, we used Pam3Cys (TLR2 ligand) and 
CpG oligodinucleotides (TLR9 ligand) to stimulate infected macrophages. Figure 2.2A 
shows that both TLR2 and TLR9-induced TNF responses were inhibited by RH strain 
infection. We also examined the activity of agonists directed at TLR3, 5, 7, and 8, and 
while none of these induced significant amounts of TNF-α, IL-12 production was 
suppressed during triggering through these TLR (data not shown).  
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Figure 2.1 T. gondii inhibits LPS-induced TNF-α, but not IL-10 production. (A 
and B) Bone marrow-derived macrophages were infected (4: 1 ratio of tachyzoites to 
cells) with a T. gondii RH strain genetically engineered to express tandem copies of 
yellow fluorescence protein (YFP). After 12 hr, cells were prepared for fluorescence 
microscopy (A) and flow cytometry (B). (C and D) 12 hr-infected macrophages were 
stimulated with LPS (closed bars) or cultured in medium alone (open bars), and then 
supernatants were collected 6 hr later for TNF-α (C) and IL-10 (D) ELISA. (E and F) 
Macrophages were infected (4: 1 ratio of parasites to cells) then 12 hr later subjected 
to LPS stimulation. At the indicated time-points, RNA was extracted, reverse 
transcribed into cDNA and real time PCR was performed for TNF-α (E) and IL-10 (F) 
transcripts. The data are normalized to GAPDH expression levels. In E and F, closed 
and open bars indicate LPS-induced responses of infected and noninfected cells, 
respectively. 
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Next, we compared highly virulent Type I Toxoplasma strains with low virulence Type 
II strains to ask whether inhibition was specific for RH or whether other strains could 
suppress TNF-α production. As shown in Figure 2.2B, although RH was the most 
potent suppressor of TNF-α, another Type I strain (ENT) also blocked TNF production. 
In addition, the Type II strains CC and DEG also possessed suppressive activity.   
 
T. gondii blocks RNA polymerase II recruitment to the TNF gene  
Regulation of TNF-α is complex, with control being exerted at transcriptional and 
post-transcriptional levels. In order to determine if Toxoplasma acts at the 
transcriptional level to interfere with TNF-α production, we examined recruitment of 
RNA polymerase II to the TNF-α gene start codon using ChIP analysis with 3 
independent sets of primers. As shown in Fig. 2.3A, LPS stimulated RNA polymerase 
II recruitment to the TNF-α promoter. In contr ast, parasite infection alone failed to 
trigger recruitment. Importantly, when cells were pre-infected with T. gondii, LPS 
stimulation failed to induce upregulation of RNA polymerase II activity at the TNF-α 
promoter. In order to substantiate this finding, we switched to a real time PCR-based 
approach to examine ChIP products using two additional primer sets for amplification. 
In both cases, while LPS induced increased RNA polymerase II recruitment to the 
promoter, parasite infection blocked this response (Fig. 2.3B and C). We conclude that 
T. gondii prevents TNF-α protein release, at least in part, through interference with 
recruitment of RNA polymerase II to the TNF gene transcription start site.  
 
T. gondii blocks LPS-induced nuclear accumulation of c-Jun, but not CREB or NFκB 
p65  
In order to elucidate the molecular basis by which T. gondii inhibits TNF-α gene 
induction, we first focused on transcription factors that target the TNF promoter (Fig. 
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Figure 2.2 T. gondii inhibits TNF-α induction by multiple Toll-like receptor 
ligands and multiple parasite strains inhibit TNF-α induction. (A) Bone marrow-
derived macrophages were infected with RH strain tachyzoites for 12 hr, followed by 
6 hr stimulation with LPS, Pam3Cys or CpG. Supernatants were collected for 
subsequent TNF ELISA. (B) Macrophages were infected with RH, CC, ENT or DEG 
strain tachyzoites for 12 hr, followed by 6 hr stimulation with LPS. Supernatants were 
collected for subsequent TNF ELISA. 
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Figure 2.3 T. gondii blocks RNA polymerase II recruitment to the TNF gene. 
Macrophages were infected with RH strain tachyzoites for 12 hr, followed by 30 min 
stimulation with LPS. Nuclear extracts were prepared and subjected to chromatin 
immunoprecipitation (ChIP) assay using antibody against RNA polymerase II. (A) 
ChIP DNA was amplified by standard PCR methodology using primers spanning the 5’ 
region of the TNF gene, and input DNA was amplified as a control. (B and C) ChIP 
DNA was amplified by real-time PCR using two different primer sets spanning the 5’ 
end of the TNF gene. The data was normalized to input DNA and amplification was 
expressed as relative enrichment compared to cells in medium (defined as 1). Med, 
cells incubated in medium alone; Tg, cells infected with Toxoplasma. *, p < 0.01 
comparing LPS and Tg+LPS. 
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2.4A). Previous studies have established that both proximal and distal regions of the 
promoter are important for maximal TNF induction (16, 19, 20). The distal region (-
500 to -900) contains four NFκB binding sites, and of these there is evidence that the 
κB2 and κB3 sites are the most active (20). The proximal region (0 to -200) contains 
binding sites for multiple transcription factors including CREB, ATF-2, c-Jun, Ets/Elk, 
Egr-1 and Sp1 (Fig. 4A). CREB, ATF-2 and c-Jun each recognize a conserved cAMP-
responsive element (CRE) palindrome. CBP/p300 serves as a platform to bring all the 
transcription factors together to form an enhanceosome and also functions as a histone 
acetylase (28, 29).  
 
We chose to examine the activation and binding properties of CREB, c-Jun and NFκB 
p65 upon TLR4 triggering of infected and noninfected cells. In Fig. 2.4B, we 
examined total and phosphorylated levels of c-Jun and CREB in macrophage nuclear 
extracts from noninfected and infected cells stimulated with LPS. Stimulation through 
TLR4 led to strong phosphorylation of c-Jun that was apparent at 30 min and 
sustained for at least 2 hr. Interestingly, in cells pre-infected with Toxoplasma, levels 
of nuclear phospho-c-Jun activation were lower. Most strikingly, we found a major 
decrease in total nuclear c-Jun following LPS stimulation of infected macrophages 
(Fig. 2.4B). LPS stimulation also resulted in modestly increased amounts of phospho-
CREB in the nuclei of non-infected macrophages, but, with the possible exception of 
the 120 min time point, T. gondii pre-infection failed to have a major effect on 
phosphorylated or total nuclear CREB levels (Fig. 2.4B).  
 
Next, we examined the influence of T. gondii on LPS-induced NFκB nuclear 
translocation. We and others previously reported that the parasite interferes with 
nuclear accumulation of this transcription factor, but this block was not sustained 
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beyond 6 hr of infection (9). In Fig. 2.4C, we show that LPS induces nuclear 
accumulation of NFκB p65 within 30 min of stimulation that was maintained for at 
least 60 min. In accord with previous data, 12-hr pre-infected cells responded with 
similar rapid NFκB p65 translocation in response to TLR4 triggering (Fig. 2.4C). We 
then assessed the binding activity of nuclear NFκB p65 after LPS stimulation in the 
presence and absence of infection. As shown in Fig. 2.4D, LPS induced a 5-fold 
increase in NFκB p65 binding activity, as measured in a binding assay using plate-
bound κB consensus target oligonucleotides. As expected, parasite infection alone 
failed to increase nuclear NFκB binding activity, and presence of tachyzoites in 
macrophages did not significantly diminish the LPS-induced increase in nuclear p65 
binding (Fig. 2.4D). We attempted a similar assay to assess CREB binding activity, but 
were unable to obtain consistent results (data not shown).  
    
T. gondii blocks binding of NFκB p65 and phosphorylated c-Jun to the TNF promoter  
We next determined the influence of Toxoplasma on recruitment of NFκB p65, 
phospho-CREB, and phospho-c-Jun to the TNF-α promoter region in live cells using 
ChIP assays. As shown in Fig. 2.5A, LPS stimulated strong binding of p65 to the TNF 
distal promoter region. In sharp contrast, T. gondii infection potently blocked 
recruitment of p65 to κB sites on the TNF-α promoter. Thus, even though NFκB 
translocated to the nucleus normally in infected cells (Fig. 2.4C), and even though this 
transcription factor was functional based upon in vitro binding assays (Fig. 2.4D), it 
was prevented from binding to its target promoter sequence (Fig. 2.5A). We observed 
a similar pattern when we examined the effect of Toxoplasma on phospho-CREB 
recruitment to the TNF promoter, although in this case parasite-mediated inhibition 
did not reach statistical significance. When we examined phospho-c-Jun, we found 
that LPS triggered strong binding to the TNF promoter and that this response was  
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Figure 2.4 T. gondii blocks LPS-induced nuclear translocation of c-Jun, but not 
that of CREB or NFκB p65. (A) Schematic map of the mouse TNF promoter 
showing distal and proximal sites involved in transcriptional initiation. (B) 
Macrophages were either infected or left uninfected for 12 hr and then subjected to 
LPS stimulation for the indicated time periods (min). Western blotting for total and 
activated forms of c-Jun and CREB was performed on nuclear lysates. Blotting for the 
nuclear enzyme PARP was performed to confirm equal protein loading. (C) 
Cytoplasmic and nuclear extracts were prepared from infected and noninfected 
macrophages stimulated with LPS for the indicated time periods (min). The extracts 
were subsequently probed with antibody to NFκB p65. In (D) the in vivo binding 
capability of nuclear NFκB p65 was determined using an ELISA-based method to 
measure transcription factor binding to solid-phase target oligonucleotides. In this 
panel, addition of soluble target oligonucleotide (Oligo Comp) blocked p65 binding, 
confirming the specificity of the assay. Med, cells cultured in medium alone; Tg, T. 
gondii infected cells. n.s., not significant comparing LPS and Tg+LPS. 
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Figure 2.5 T. gondii blocks LPS-induced binding of phosphorylated c-Jun and 
NFκB p65 to the TNF promoter. Bone marrow-derived macrophages were infected 
with RH strain tachyzoites then 12 hr later subjected to 30 min LPS stimulation. ChIP 
assays were performed using antibodies specific for NFκB p65 (A), phospho-CREB 
(B) and phospho-c-Jun (C). The immunoprecipitated DNA was amplified by real-time 
PCR using primers spanning either proximal (for c-Jun and CREB) or distal (for 
NFκB p65) sites of the TNF promoter. The results were normalized to the input DNA 
and expressed as Relative Quantitation (RQ) where medium is defined as 1. Med, 
medium; Tg, cells infected with T. gondii. n.s., not significant; *, p < 0.01 comparing 
LPS and Tg+LPS. 
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strongly down-modulated by prior T. gondii infection (Fig. 2.5C). While the latter 
result was not entirely unexpected based upon decreased levels of total c-Jun in the 
nucleus during infection, it is notable that substantial amounts of phosphorylated 
nuclear c-Jun remained in infected cells (Fig. 2.4B).  
 
Toxoplasma interferes with histone H3 modification associated with gene 
transcriptional activation  
The finding that T. gondii potently blocked recruitment of transcription factors to the 
TNF-α promoter without interfering with activation or nuclear translocation suggested 
that the parasite might target chromatin structure rather than transcription factors per 
se. Therefore, we sought to determine the influence of Toxoplasma on Lys9/14 
acetylation and Ser10 phosphorylation of histone H3, modifications that are associated 
with chromatin decondensation and gene activation (30). We found that even 
nonstimulated macrophages expressed high amounts of acetylated histone H3, and 
levels were not changed by LPS stimulation in the presence or absence of infection 
(Fig. 2.6A). These results were confirmed by immunofluorescence microscopy (Fig. 
2.6B). However, we found that LPS induced phosphorylation of histone H3 within 60 
min of stimulation, and this response was strongly inhibited in parasite-infected 
macrophages (Fig. 2.6A). Likewise, immunofluorescence microscopy confirmed 
inhibition of histone H3 phosphorylation in TLR4-triggered infected cells, in contrast 
to noninfected macrophages that were stimulated with LPS (Fig. 2.6B and 2.6C). The 
kinase MSK1 elicits histone H3 phosphorylation on the Ser10 residue (31, 32). 
Therefore, we asked whether LPS triggered activation of MSK1, and, in turn, whether 
T. gondii blocked the response. While LPS stimulated rapid activation of MSK1, the 
response was unaffected by prior infection with Toxoplasma (Fig. 2.6D). We also 
examined histone H3 Thr3 and Ser28 modification, but found little or no effect of  
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Figure 2.6 T. gondii globally blocks LPS-induced phosphorylation of histone H3 
at Ser 10 but has no effect on Lys 9/14 histone H3 acetylation. (A) Macrophages 
were infected then 12 hr later subjected to LPS stimulation for indicated time periods 
(min). Total cell lysates were extracted and subjected to Western blotting using 
antibodies specific to phospho-Ser10 histone H3, acetyl-Lys9/14 and total H3. In (B), 
fluorescence microscopy was employed to examine Lys9/14 acetylation (top panels) 
and Ser10
 
 phosphorylation (bottom panels) of histone H3 in infected and noninfected 
cells stimulated for 30 min with LPS. Macrophages were stained with antibody 
specific for acetylated or phosphorylated histone H3 as indicated (Red) and 
Toxoplasma p30 (Green). Nuclei are stained with DAPI (Blue). In (C), cells that were 
positive for phospho-Ser10 at histone H3 staining were counted in each group of cells 
(approximately 200 cells per condition). *, p < 0.01 comparing infected and non-
infected cells. (D) 12-hr-infected and control macrophages were stimulated with LPS 
(100 ng/ml) and cell lysates were prepared at the indicated time points (min). 
Immunoblotting for phospho-MSK1 was subsequently performed. As a control for 
protein loading, levels of histone H3 were assessed in the same samples. Med, 
medium; Tg, T. gondii. 
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Toxoplasma on the phosphorylation status of these residues (data not shown). 
 
We next wanted to specifically examine the status of histone H3 modification 
surrounding distal and proximal regions of the TNF-α promoter during macrophage 
activation in the presence and absence of infection, since global levels of H3 
phosphorylation and acetylation might not be reflective of histone modification at the 
TNF promoter. Therefore, we examined histone modifications at this site by ChIP 
assay. We found that LPS induced elevated levels of phosphorylation of histone H3 at 
serine 10 at both distal and proximal TNF promoter regions (Figure 2.7A and 2.7C). 
Notably, this response was blocked by Toxoplasma infection. Furthermore, we also 
examined acetylation of histone H3 at lysine 9 and lysine 14 at proximal and distal 
locations of the TNF promoter (Figure 2.7B and 2.D). While LPS induced H3 
acetylation at both sites, this response was blocked in infected macrophages. Finally, 
we examined the status of histone H3 surrounding the IL-10 promoter, an LPS-
induced gene that is not affected by Toxoplasma (Fig. 2.1). In this case, there was no 
evidence for histone H3 modification following TLR4 stimulation as measured by 
phosphorylation (Fig. 2.7E) or acetylation (Fig. 2.7F), and infection with T. gondii had 
no influence in the presence or absence of LPS. Therefore, while global levels of 
acetylated histone H3 are not affected by Toxoplasma, the parasite down-regulates 
acetylated H3 at the TNF promoter. In contrast, the parasite blocks LPS-induced Ser10
 
 
H3 phosphorylation at the global level and this extends to the activity at the TNF 
promoter. 
Toxoplasma suppresses TNF-α production during in vivo infection    
We wanted to determine if parasite suppression of bone marrow-derived macrophage 
TNF-α production extended to in vivo infection. Therefore, we assessed production of  
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Figure 2.7 T. gondii blocks LPS-induced histone H3 modification at the TNF 
promoter. Macrophages were infected with T. gondii then 12 hr later subjected to LPS 
stimulation for 30 min. The cells were fixed with formaldehyde and ChIP assay 
performed using antibodies specific for Ser10 phosphorylated (A and C) or Lys9/14
 
 
acetylated (B and D) histone H3. The resulting DNA was amplified by real time PCR 
using primers spanning either proximal (A and B) or distal (C and D) sites of the TNF 
promoter region. As a control, the same ChIP DNA was amplified using primers 
spanning IL10 promoter region (E and F). The results were normalized to the input 
DNA and expressed as Relative Quantitation (RQ), with medium defined as 1. Med, 
cells incubated in medium alone; Tg, cells infected with Toxoplasma. *, p < 0.05 
comparing LPS and Tg+LPS. 
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this cytokine by inflammatory macrophages recruited to the peritoneal cavity during 
infection. Mice were inoculated by i.p. injection with Toxoplasma, and peritoneal 
wash-out cells were collected 12 hrs later. The cells were cultured in vitro in medium 
or LPS, and TNF-α production was assessed in infected and noninfected populations 
of F4/80-positive macrophages (Fig. 2.8A). As shown in Fig. 2.8B, in cells cultured 
without further stimulation, 13% of noninfected macrophages produced TNF-α. In 
contrast, only 3% of infected macrophages produced this cytokine in the same overall 
population. When F4/80-positive macrophages were stimulated ex vivo with LPS (Fig. 
2.8C), 84% of noninfected macrophages produced TNF-α. Strikingly, in the infected 
cell population, only 25% stained positive for TNF-α in response to ex vivo TLR4 
triggering. We note that in the F4/80-positive population, a distinct subset of cells 
harbors low parasite levels and can respond to LPS (Fig. 2.8C), a distribution pattern 
that we do not see in vitro (Fig. 2.1B). We do not know the origin of these 
macrophages at present. One possibility is that these are cells that were newly infected 
during the in vitro response to LPS. Another possibility is that this population 
represents a macrophage subset that is less permissive to T. gondii replication and is 
also less sensitive to parasite-induced inhibition of TNF-α. Regardless, our data for the 
first time show that Toxoplasma shuts down proinflammatory signaling in an in vivo 
situation. 
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Figure 2.8 T. gondii inhibits TNF-α production during in vivo infection of F4/80-
positive macrophages. Mice were infected by intraperitoneal injection of 106
 
 RH 
strain tachyzoites. After 12 hr, cells in the peritoneal cavity were collected and 
cultured for 6 hr in either medium alone or LPS in the presence of Brefeldin A. Cells 
were then subjected to surface staining for F4/80 and intracellular staining for TNF-α 
and Toxoplasma p30 (SAG-1) to detect tachyzoites. A, F4/80-positive cells in the 
peritoneal cavity. The rectangle delineates cells selected for analysis. B, TNF-α and 
infection levels in F4/80-positive cells cultured in medium. C, TNF-α and infection 
levels in F4/80-positive cells stimulated in vitro with LPS. 
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DISCUSSION 
Microbial pathogens such as Toxoplasma must evade the potent antimicrobial effects 
of proinflammatory mediators produced by the innate immune system if they are to 
establish persistent infection in the host. For intracellular pathogens, direct 
interference with gene transcription is a highly effective strategy to achieve this end 
(33, 34). Inflammatory gene expression is controlled by multiple regulatory signal 
transduction cascades (35). First, gene-specific transcription factors must be activated 
and translocated to the nucleus. Second, it is becoming increasingly realized that in 
many cases chromatin structure surrounding target genes must be modified to allow 
access of transcription factors (36-38). There are many examples of pathogens that 
target pathways leading to transcription factor activation. A more limited number of 
recent studies have found that some bacterial pathogens epigenetically affect gene 
function (39-42). This study is the first example of a eukaryotic pathogen that targets 
regulatory cascades controlling chromatin structure to subvert host cell function.  
 
The four core histones (H2A, H2B, H3 and H4) that make up the nucleosome are 
arranged as an octamer around which DNA is wound. The N termini of the histones 
are subject to covalent modification that can be associated with repression or induction 
of genes (36-38). Transcriptional activation is strongly associated with histone H3 
modification. The pattern of chemical changes is complex but among the 
modifications, phosphorylation of Ser10 and acetylation of Lys9 and Lys14
 
 are linked to 
changes in chromatin structure that permit access of transcription factors (30).  
Our results for the first time show that T. gondii prevents chromatin remodeling 
surrounding the TNF-α promoter by interfering with phosphorylation and acetylation 
of histone H3 that would otherwise be induced by TLR signaling. We found that 
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Toxoplasma blocks Ser10 phosphorylation of total histone H3 in the nucleus, as well as 
at distal and proximal TNF-α promoter regions. Our studies in addition show that T. 
gondii interferes with LPS-induced acetylation of histone H3 at Lys9 and Lys14 
surrounding the TNF promoter. Interestingly, this was a gene-specific effect because 
global levels of acetylated H3 were constitutively high in macrophages, and neither 
LPS nor the combination of Toxoplasma and LPS altered these levels. Ser10 
phosphorylation of histone H3 can recruit several histone acetyl transferases to 
catalyze acetylation of Lys9 and Lys14 (43, 44). Therefore, it is possible that the effects 
of Toxoplasma on histone H3 acetylation at the TNF promoter are indirectly mediated 
by inhibition of H3 Ser10
 
 phosphorylation. Insofar as chromatin modification is a 
prerequisite to allow transcription factor access at many proinflammatory genes, our 
results may provide a unifying model for the parasite’s ability to simultaneously 
down-regulate production of several proinflammatory mediators in addition to TNF-α 
(5, 14).  
Although Toxoplasma down-modulates many TLR4-inducible genes, some escape 
inhibition. Most prominently, we found that LPS-triggered IL-10 is not blocked by the 
parasite. We also found no evidence that LPS altered chromatin modification 
surrounding the IL-10 promoter. Thus, the relatively low amount of LPS-triggered IL-
10 compared to TNF-α appears to be produced independently of histone H3 
Ser10 phosphorylation or Lys9/14
 
 acetylation, and therefore escapes inhibition by the 
parasite. In contrast, there is evidence that high level IL-10 transcription induced by 
other stimuli such as combined treatment with LPS and immune complexes involves 
chromatin remodeling at the IL-10 promoter (45). We are currently examining whether 
these responses are likewise affected by Toxoplasma.      
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While interference with chromatin remodeling is likely to be a potent parasite 
mechanism to manipulate the host cell transcriptome, we also found evidence for 
interference with c-Jun activity. Thus, total levels of nuclear c-Jun rapidly decreased 
following LPS stimulation of infected macrophages. One interpretation of this result is 
that TLR4 triggering causes phosphorylation of nuclear c-Jun, and Toxoplasma 
increases nuclear export of the activated form of this transcription factor. Unlike the 
results of the 12 hr infections reported here, the parasite also prevents nuclear 
accumulation of NFκB during short-term infection. Whether this reflects decreased 
nuclear import or increased export is unclear (4, 10, 46). 
 
Toxoplasma is sequestered within a parasitophorous vacuole, but recent findings show 
that the parasite delivers molecules to the host cell to modify signal transduction (47). 
During host cell invasion, apical organelles called rhoptries discharge and at least 
some rhoptry proteins enter the host cell. The ROP16 molecule, a rhoptry protein with 
predicted kinase activity, is released during invasion and targets STAT3/6 for 
activation (12). STAT3 activation by T. gondii has previously been implicated in 
suppression of IL-12 by the parasite (11). In addition a protein phosphatase 2C 
released by the parasite is targeted to the host cell nucleus, although in this case host 
target molecules have not yet been identified (48). Nevertheless, the emerging opinion 
is that T. gondii takes an active part in manipulation of the host cell (13, 47, 49), and 
the results of the present study provide strong mechanistic evidence for this view. 
Toxoplasma inhibits signaling through TLR, yet the parasite itself expresses its own 
TLR ligands. Tachyzoite profilin activates TLR11 and glycosylphosphoinositol (GPI) 
anchors on the parasite surface are capable of triggering TLR2 and TLR4 (50, 51). The 
parasite cannot survive without profilin, which is used in invasion (52). Likewise, the 
parasite is not viable without the ability to synthesize GPI-anchored proteins (53). 
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Possibly for these reasons T. gondii has adopted potent strategies to down-modulate 
proinflammatory signaling that would otherwise result from recognition of its own 
essential molecules by host pattern recognition receptors. 
 
Several bacterial pathogens target proinflammatory signaling pathways in 
macrophages. The Yersinia virulence proteins YopP/J block phosphorylation of IκB 
and MAPK kinase, effectively terminating both NFκB and MAPK signal transduction 
(54-57). Along similar lines Bacillis anthracis lethal factor (LF) enzymatically cleaves 
MAPK kinases (58). Some bacterial pathogens can also affect chromatin structure. 
Mycobacerium tuberculosis downregulates histone acetylation around the MHC2TA 
locus, and Listeria monocytogenes dephosphorylates histone H3 and deacetylates 
histone H4 during early infection (39-41). It has recently been reported that Shigella 
flexneri escapes inflammatory chemokine induction through effects of the OspF 
protein on histone H3 phosphorylation (42). Intracellular protozoans are now also 
emerging as master evaders of immunity (34). Toxoplasma has negative effects on 
MAPK, NFκB as well as STAT1 signaling pathways, although the mechanisms 
involved are less well defined (9, 59, 60). Our present studies reveal gene-specific 
targeting of chromatin structure as a new and profound strategy used by this 
intracellular protozoan to manipulate host cell responses. 
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CHAPTER THREE 
 
Toxoplasma gondii Inhibits Chromatin Remodeling at 
the IL-10 Promoter Triggered by Immune Complex 
plus LPS 
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ABSTRACT 
IL-10 is an important immune regulatory cytokine. Macrophages stimulated with LPS 
produce low amounts of IL-10. Previously, we found that the opportunistic protozoan 
Toxoplasma gondii does not influence IL-10 production in macrophages upon LPS 
stimulation, the latter of which does not incur chromatin remodeling. However, we 
find here that infection does block the high level of IL-10 production in macrophages 
stimulated with LPS plus immune complex. In this study, we also found that LPS plus 
immune complex stimulation triggers chromatin remodeling at the IL-10 promoter and 
that infection blocks chromatin remodeling. Specifically, the parasite inhibits the Ser10 
phosphorylation and Lys9/Lys14
 
 acetylation on the IL-10 promoter. Our results show 
that Toxoplasma inhibits IL-10 transcription by interfering with chromatin remodeling 
events required for transcriptional activation on the IL-10 promoter.   
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INTRODUCTION 
Macrophages play a key role in innate immunity. When activated by bacterial products 
such as LPS, they produce a variety of inflammatory cytokines including TNF, IL-1, 
IL-6 and IL-12. This inflammatory response is critical in clearing the infection. To 
avoid immunopathological damage to the host, inflammation needs to be tightly 
controlled by the immune system. Anti-inflammatory regulatory cytokines such as IL-
10 and TGF-β can prevent the overproduction of inflammatory cytokines such as TNF 
and IL-12 (1, 2). 
 
Monocytes, including macrophages, are the main producers of IL-10. This cytokine 
has been shown to have pleiotropic effects in immunoregulation and inflammation. It 
down-regulates the expression of Th1 cytokines, MHC class II antigens, and 
costimulatory molecules on macrophages (3, 4). IL-10 also displays a potent ability to 
suppress the antigen presentation capacity of antigen presenting cells (5). On the other 
hand, IL-10 also enhances B cell survival, proliferation, and antibody production (6). 
This cytokine can block NF-κB activity, and is involved in the regulation of the JAK-
STAT signaling pathway (7). Knockout studies in mice suggested the function of this 
cytokine as an essential immunoregulator during Toxoplasma infection, as the knock 
out mice succumb to immunopathology due to uncontrolled inflammatory responses 
(8-10). 
 
Activated macrophages produce inflammatory cytokines such as TNFα and the 
production of IL-10 normally follows the induction of inflammatory cytokines to 
prevent their overproduction. It has been shown the LPS induced synthesis of IL-10 is 
very low (11). However, in the presence of immune complex, activated macrophages 
produce large amounts of IL-10 (12). The mechanism of this superinduction of IL-10 
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has caused much interest. Recently, it has been shown that while LPS alone does not 
induce chromatin structural changes at the IL-10 locus, immune complex does induce 
a transient chromatin remodeling at the IL-10 promoter with an increase in 
phosphorylation of histone H3 at Ser10 and acetylation of histone H3 at Lys14
 
 (13, 14). 
It was therefore proposed that LPS activates MAPK pathways and transcription factors 
such as NFκB, while immune complex induces remodeling of chromatin structure on 
the IL-10 locus. The combination of these two factors superinduces IL-10 in the 
macrophages.  
The opportunistic intracellular protozoan Toxoplasma gondii actively inhibits a large 
panel of immune cytokine genes upon LPS stimulation including IL-12p40 and TNFα 
(15, 16). It has been shown that T. gondii inhibits the TNFα response by blocking 
histone modifications required for TNFα gene transcription (11). We also found that T. 
gondii infection does not influence the low level of IL-10 induction by LPS. It was 
therefore interesting to investigate whether the parasite is able to block the 
superinduction of IL-10 by LPS plus immune complex, especially since this 
superinduction requires chromatin remodeling on the IL-10 locus. 
 
In this study, we show that T. gondii inhibits the IL-10 response superinduced by LPS 
and immune complex, but not the low level of IL-10 induced by LPS alone. 
Interestingly, by examining the histone modifications occuring at the IL-10 locus, we 
found that the parasite is able to block the phosphorylation of histone H3 at Ser10 and 
acetylation of histone H3 at Lys9 and Lys14 induced by immune complex. These 
results provide further support for the idea that T. gondii targets chromatin structure to 
suppress the cytokine gene transcription. This is possibly a unifying strategy for the 
parasite’s suppressive effect. 
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MATERIAL AND METHODS 
Mice and parasite 
C57BL/6 female mice (6–8 wk of age) were purchased from The Jackson Laboratory. 
The mice were kept under specific pathogen-free conditions at the Transgenic Mouse 
Facility, Cornell University College of Veterinary Medicine. The facility is overseen 
by an Institutional Animal Care and Use Committee. T. gondii parasite RH strain was 
maintained by biweekly passage on human foreskin fibroblast monolayers in DMEM 
supplemented with 1% FCS, 100 U/ml penicillin, and 0.1 mg/ml 
streptomycin. Parasite cultures were tested for Mycoplasma every 6–8 wk using a 
highly sensitive PCR-based ELISA (Roche Diagnostics).
 
  
Cell culture 
Bone marrow cells were flushed from femur and tibia and cultured in complete 
DMEM consisting of DMEM supplemented with 10% FCS, 1 mM sodium pyruvate, 
0.1 mM nonessential amino acids, 20% supernatant from L929 cells, 100 U/ml 
penicillin, and 0.1 mg/ml streptomycin. The cells were supplemented with fresh 
macrophage medium on day 3. After 5 days of culture, nonadherent cells were 
removed, adherent monolayers were washed in ice-cold PBS, and cells were harvested 
by gentle pipetting in DMEM supplemented with 1% FCS, 100 U/ml penicillin, and 
0.1 mg/ml streptomycin. Infection of macrophages was accomplished by adding 
tachyzoites to cell cultures followed by brief centrifugation (200 x g for 3 min) to 
synchronize contact between cells and parasites. In most cases, immune complex and 
LPS were added 12 h after infection. Cells were recovered at varying times as 
indicated, depending upon the assay performed.
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Immune Complex 
IgG-opsonized erythrocytes (E-IgG) were generated by incubating sheep red blood 
cells (SRBC, Lampire Biological Laboratories) with anti-SRBC IgG (MP Biomedicals) 
at nonagglutinating titers for 30 min at room temperature while rotating. 
Nonagglutinating titers were determined by titrating IgG concentrations. Opsonized 
cells were washed once in HBSS (Invitrogen Life Technologies) and resuspended in 
complete medium. E-IgG were added to macrophages at a ratio 
 
of 10:1 E-IgG to 
macrophages. 
Semiquantitative real-time PCR 
Real-time PCR was performed with a Power SYBR green kit according to the 
manufacturer’s instructions (catalog no. 4367659; 
 
Applied Biosystems). The primers 
used were as follows: IL-10 forward CCTGGCTCAGCACTGCTAT; IL-10 reverse: 
GCTCTTATTTTCACAGGGGAGAA; GAPDH forward: 
CCTGAACAGAACAGCAATGGCT; GAPDH reverse: 
GCTTGACGGTGTCTTTTGCCT; IL-10 nucleosome 2 forward: 
GCAGAAGTTCATTCCGACCA; IL-10 nucleosome 2 reverse: 
GGCTCCTCCTCCCTCTTCTA.  
Cytokine ELISA 
IL-10 in cell cultures was measured using commercial kits according to the 
manufacturer’s recommendations (R&D Systems).
 
  
Immunoblotting 
The following Abs were used in immunoblotting studies: anti-phospho-histone H3 
(Ser10; catalog no. 9701; Cell Signaling). Cells (2 x 106/sample) were lysed in reducing 
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SDS sample buffer, and DNA was sheared by forcing samples five times through a 27-
gauge needle. In some experiments, nuclear and cytoplasmic portions of cell 
lysates were separated by using a nuclear extract kit (Active Motif). After 5 min at 
100°C, samples were separated by 10% SDS-PAGE and proteins were subsequently 
electrotransferred onto nitrocellulose membranes. Membranes were then blocked in 5% 
nonfat dry milk containing 0.1% Tween 20 in TBS, pH 7.6 (TBST), for 1 hr at 
room temperature, followed by incubation with Ab reconstituted in 5% BSA in TBST 
overnight at 4°C. After washing blots in TBST, primary Abs were detected with a 
HRP-conjugated secondary Ab in TBST containing 5% nonfat dry milk for 1 hr at 
room temperature. After washing in TBST, protein bands were visualized using 
a chemiluminescence-based detection system (Cell Signaling).
 
  
Chromatin immunoprecipitation (ChIP) 
The following ChIP grade Abs were used for immunoprecipitation: anti-phospho-
histone H3 (Ser10; catalog no. 9701; Cell Signaling), and anti-acetyl histone H3 
(Lys9/Lys14; catalog no. 9677; Cell Signaling). Assays were performed using the ChIP-
IT enzymatic express kit (Active Motif) according to the manufacturer’s instructions. 
Briefly, cells (1.5 x 107/sample) were fixed using 1% formaldehyde at room 
temperature for 10 min. Fixation was stopped by adding glycine to the mixture. The 
cells were then collected by scraping in buffer containing PMSF (100 mM). After brief 
centrifugation, the cells were resuspended in lysis buffer (Active Motif) with a 
protease inhibitor mixture (Active Motif) and incubated for 30 min on ice. The cells 
were then resuspended in cell digestion buffer (Active Motif) and subjected to 
enzymatic digestion for 10 min at 37°C. The reaction was stopped with addition of 0.5 
M EDTA. Abs were added into the sheared chromatin preparations and the mixture 
was incubated with Protein G Magnetic Beads (Active Motif) overnight at 4°C. The 
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precipitated DNA-protein-Ab complexes were then washed and the cross-linking was 
reversed by incubation at 65°C for 4 h. Proteinase K was added to digest protein and 
DNA subsequently was purified using ethanol extraction, air dried, and redissolved in 
100 µl of H2O. The retrieved DNA was then subjected to real-time RT-PCR 
amplification using promoter-specific primers.
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RESULTS 
T. gondii inhibits high level IL-10 production induced by LPS plus immune complex, 
but does not influence the low level of IL-10 induced by LPS alone. 
Previously, we showed that T. gondii infection inhibits LPS induced TNFα production 
in macrophage while it has no effect on the IL-10 response induced by LPS (Chapter 
2). To confirm this result, we used the type I strain T. gondii RH strain to infect the 
macrophages. When these macrophages were stimulated with LPS, we found that the 
cells produced ~1000 pg/ml IL-10 and this response was not influenced by T. gondii 
infection (Figure 3.1). When we used LPS to stimulate the macrophages in the 
presence of immune complex, we found that the cells produced three-fold more IL-10. 
However, when macrophages were infected with Toxoplasma, this super-induction 
response was blocked. In accord with the cytokine protein data, we found that LPS 
plus immune complex induced IL-10 mRNA production was also blocked by the 
parasite (Figure 3.2). In contrast, we found that LPS induced IL-10 mRNA was left 
inact in the presence of infection (data not shown). 
 
IL-10 promoter chromatin remodeling induced by immune complex plus LPS is 
blocked by T. gondii  
It has been shown that immune complex induces chromatin remodeling at the IL-10 
locus. Stimulation induces a transient increase in the phosphorylation of histone H3 at 
Ser10 followed by an increase in the acetylation of histone H3 at Lys14. This process 
enables remodeling of chromatin structure at the IL-10 locus and allows the binding of 
activated transcription factors at the IL-10 promoter. We therefore sought to 
investigate the influence of T. gondii infection on the histone modifications at the IL-
10 locus induced by immune complex. We used the type I strain T. gondii RH strain to 
infect macrophages. The cells were then stimulated with LPS alone or a combination  
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Figure 3.1 Toxoplasma inhibits IL-10 protein superinduced by LPS and immune 
complex. Macrophages were infected with T. gondii RH strain tachyzoites at a 
parasite to cell ratio of 2:1. After 18 hr, cells were treated with either LPS (10 ng/ml) 
or immune complex plus LPS. The supernatants were collected 6 hr later and cytokine 
ELISA was performed to measure IL-10 concentrations. Med, medium; Tg, T. gondii; 
IC, immune complex. 
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Figure 3.2 Toxoplasma inhibits IL-10 mRNA superinduced by LPS and immune 
complex. Macrophages were infected with T. gondii RH strain tachyzoites at a 
parasite to cell ratio of 2:1 for 18 hr. The cells were then subjected to immune 
complex plus LPS (10ng/ml) stimulation. RNA was then extracted at indicated time 
points (hr) and reversed transcribed into cDNA. Real time PCR was performed to 
measure the IL-10 mRNA. GAPDH was used as an internal control. M, medium; IC, 
immune complex; R, RH strain; L, LPS. 
 
 
IC+LPS 10ng/ml
0 1 2 6
0
200
400
600
800
1000
M+IC+L
R+IC+L
Time post IC+LPS stimulation
82 
 
of LPS and immune complex. We chose to examine the phosphorylation of histone H3 
at Ser10 at 30 minutes post stimulation and the acetylation of histone H3 at Lys9/Lys14
 
 
at 60 minutes post stimulation as these two time points have been shown to be the 
peak time for these two histone modifications, respectively (13). Using a chromatin 
immunoprecipitation (ChIP) assay, we found that while LPS alone does not induce 
any chromatin changes on the IL-10 locus, LPS combined with immune complex 
induces an increase of both modifications at 30 and 60 minutes post stimulation, 
respectively. However, infection with T. gondii inhibits both histone modifications 
induced by LPS and immune complex, while having no effects on LPS stimulated 
cells (Figure 3.3 and 3.4).  
T. gondii inhibits global phosphorylation of histone H3 at Ser10
Previously in Chapter 2 we showed that T. gondii infection blocks LPS induced global 
phosphorylation of histone H3 at Ser
 induced by LPS or 
Immune Complex  
10 in macrophages. We were then interested in 
examining whether immune complex in the presence of LPS induced global 
phosphorylation of histone H3 at Ser10 and whether this response is influenced by the 
parasite. When macrophages were stimulated with LPS at 10 ng/ml, we detected an 
increased global level of phosphorylation of histone H3 at Ser10 in cell lysates, which 
starts 30 min post stimulation and lasts up to 120 min post stimulation. Upon infection 
with RH, phosphorylation of histone H3 at Ser10 in cell lysates is greatly decreased. 
With a combination of immune complex and LPS, we are able to induce a similar 
response in macrophages, and as we expected, immune complex and LPS induced 
phosphorylation of histone H3 at Ser10
 
 was also blocked by T. gondii infection (Figure 
3.5).   
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Figure 3.3 Toxoplasma infection blocks phosphorylation of histone H3 at Ser 10 
at the IL-10 promoter induced by LPS and immune complex. Macrophages were 
infected with T. gondii RH strain tachyzoites at a parasite to cell ratio of 2:1. After 
overnight infection, the cells were then subjected to either LPS (100 ng/ml) or immune 
complex plus LPS stimulation. The nuclei from each sample was extracted at 30 mins 
post stimulation and then subjected to ChIP assay using antibody against 
phosphorylated H3 at Ser10 and primers specific for the IL-10 promoter. The results 
were normalized to corresponding input controls. Med, medium; Tg, T. gondii; IC, 
immune complex. 
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Figure 3.4 Toxoplasma infection blocks acetylation of histone H3 at Lys9/Lys14 at 
the IL-10 promoter induced by LPS and immune complex. Macrophages were 
infected with T. gondii RH strain tachyzoites at a parasite to cell ratio of 2:1. After 
overnight infection, the cells were then subjected to either LPS (100ng/ml) or immune 
complex plus LPS stimulation. The nuclei from each sample was extracted at 60 mins 
post stimulation and then subjected to ChIP assay using antibody against acetylated 
H3 at Lys9/Lys14
 
 and primers specific for the IL-10 promoter. The results were 
normalized to corresponding input controls. Med, medium; Tg, T. gondii; IC, immune 
complex. 
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Figure 3.5 Toxoplasma blocks immune complex and LPS induced global 
phosphorylation of H3 at Ser10. Macrophages were infected with T. gondii RH strain 
tachyzoites at a parasite to cell ratio of 2:1. 18 hr later, the cells were subjected to 
either LPS (10 ng/ml) or immune complex plus LPS stimulation. The cells were lysed 
at indicated time points (mins) and cell lysates were subjected to Western Blotting 
assay using antibody against phosphorylated H3 at Ser10. Total H3 was used to control 
the protein loading amounts. Tg, T. gondii; IC, immune complex.   
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Only Type I Toxoplasma RH strain inhibits IL-10 induced by Immune Complex plus 
LPS 
Up to now we have confirmed that Toxoplasma Type I RH strain inhibits IL-10 super-
induction by immune complex in the presence of LPS. We were then interested to 
know whether other T. gondii strains, especially Type II and Type III strains, have a 
similar effect on the immune complex induced IL-10 response. In these experiments, 
we used Type II PTG and Type III VEG tachyzoites to infect macrophages and then 
subjected the infected cells to immune complex stimulation. To our surprise, the tested 
Type II and Type III strains did not have an obvious inhibitory effect on immune 
complex induced IL-10 compared to Type I RH strain (Figure 3.6). Instead, we 
observed a synergistic effect of PTG on IL-10 production at low MOI no matter 
whether the cells were treated with LPS or immune complex plus LPS. Although we 
have not yet tested additional strains, our results suggest that only the Type I strain 
inhibits IL-10 super-induction by immune complex and LPS. We need to validate 
these preliminary results by performing more repeats. 
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Figure 3.6 Toxoplasma Type II and Type III strains do not inhibit IL-10 super-
induction by immune complex and LPS. Macrophages were infected with T. gondii 
RH, PTG or VEG strain tachyzoites at indicated parasite to cell ratios. The cells were 
then subjected to either LPS (100 ng/ml) or immune complex plus LPS stimulation. 
Supernatants were collected 6h later and subjected to cytokine ELISA to measure the 
IL-10 concentrations. IC, immune complex.  
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DISCUSSION 
The opportunistic intracellular parasite T. gondii actively suppresses the 
proinflammatory responses in macrophages. In Chapter 2, we showed that the parasite 
inhibits the LPS-induced TNFα response in macrophages by interfering with 
chromatin remodeling at the TNF promoter region required for transcriptional 
initiation. In this way, the parasite prevents the binding of activated transcription 
factors to the promoter region.  
 
In the previous study, we also found that LPS induced a low amount of IL-10 
production in macrophages, and T. gondii did not block this response. In terms of 
chromatin remodeling, we found that LPS did not induce any chromatin structural 
changes at IL-10 locus and the parasite had no influence on the IL-10 locus (11). Since 
macrophage activation in the presence of immune complex induces a high level of IL-
10 and this response requires chromatin remodeling on the IL-10 locus, we were 
intrigued to investigate whether T. gondii inhibits IL-10 superinduced by LPS and 
immune complex. Furthermore, it was of interest to know if the parasite blocks histone 
modifications on the IL-10 locus upon superinduction with LPS and immune complex. 
 
In this study, we found that T. gondii inhibits high level IL-10 production induced by 
LPS plus immune complex, but does not influence the low level of IL-10 induced by 
LPS alone. Moreover, immune complex/LPS induced IL-10 promoter chromatin 
remodeling was also blocked by the parasite. In some ways, these results are within 
our expectations as we previously found that the parasite uses a similar strategy to 
inhibit the TNFα response induced by LPS.  
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The immune complex induced IL-10 response is found to involve FcγR ligation 
followed by ERK and p38 activation (14). ERK activation leads to phosphorylation of 
histone H3 Ser10
 
. However, when p38 or ERK activity is inhibited, the IL-10 response 
is blocked indicating that both MAPKs are required for super-induction of IL-10. Our 
study did not examine the effect of T. gondii on activation of p38 or ERK by immune 
complex and LPS, but it remains possible that the parasite also interferes with these 
two MAPKs. 
Even though the Toxoplasma  parasitophorous vacuole evades fusion with the host 
lysosome, the parasite still manages to deliver some molecules to the host cell nucleus 
although the exact functions of these molecules are still under investigation. For 
example, PP2C-hn, a parasite phosphatase, is injected into the host nuclei after 
invasion. Although disruption of PP2C-hn had no obvious effects on parasite growth, 
it is still possible that some host elements are modulated by this phosphatase (17). 
Another parasite rhoptry protein, ROP16, is found to accumulate inside host nuclei 
shortly after invasion.  ROP16 contains a kinase domain and is indirectly related with 
the rapid and sustained tyrosine phosphorylation of host STAT3 after infection (18, 
19), because ROP16 is a putative serine/threonine kinase.  
 
Combining the findings in this Chapter and Chapter 2, it is reasonable to speculate that 
some parasite effector proteins target the host nucleus, especially host chromatin 
structure to fulfill their functions such as shutting down some sets of genes while 
activating others to benefit the parasite’s intracellular survival.  Another possibility is 
that the parasite can act in the cytoplasm by interfering with activation and/or nuclear 
translocation of host effectors.   
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We also observed in this study that Toxoplasma is able to block the global 
phosphorylation of histone H3 at Ser 10 induced by immune complex and LPS. This is 
within our expectations since we obtained similar data with LPS stimulation. The 
parasite’s ability to shut down the global phosphorylation of histone H3 at Ser10 is of 
great significance as the epigenetic signal of phosphorylation of histone H3 at Ser10 is 
shown to be important for transcription of many genes, including those controlled by 
NFκB. Studies showed that phosphorylation of histone H3 at Ser10 allows binding 
access to NFκB on some cytokine and chemokine gene promoters, such as IL-8 (20, 
21). Therefore, Toxoplasma’s ability to inhibit phosphorylation of histone H3 at Ser10
 
 
might be involved in its ability to shut down a large panel of inflammatory genes. 
Future studies will be required to further evaluate this hypothesis.  
By comparing all three types of Toxoplasma, we found that only Type I RH strain 
clearly inhibits IL-10 superinduction by immune complex and LPS. However, we are 
not yet able to conclude the effects of Type II PTG and Type III VEG strains on IL-10 
superinduction. This is interesting because Type I strains are the most virulent during 
in vivo infection and Type II and Type III are more moderate.  
 
With the future identification of parasite molecules that are delivered into host cell, we 
can expect to see more functions to be discovered. In particular, we can expect to 
determine molecules involved in the modulation of host signaling and possibly in the 
interference of host chromatin remodeling.  
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CHAPTER FOUR 
 
Molecular Characterization of Immunosuppression by 
Toxoplasma gondii: Further Studies 
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ABSTRACT 
In this study, we further examined the characteristics of suppression mediated by 
Toxoplasma gondii. We examined the influence of T. gondii infection on both MyD88 
dependent and independent TLR signaling pathways in macrophages. During 
stimulation with various ligands of different TLR, we found that T. gondii blocks the 
IL-12 response induced by these ligands. In addition, we examined the MyD88 
independent TLR signaling pathways triggered by TLR3 and TLR4 that lead to Type I 
Interferon production. These responses were also inhibited by the parasite. We also 
compared the effects of different parasite strains on TNF production in dendritic cells. 
We found that only Type I strain parasites inhibited TNF production in dendritic cells. 
We then examined the effects of different parasite strains on the global level of 
phosphorylation of histone H3 at Ser10
 
 in macrophages and found that the Type I RH 
strain has the most potent inhibitory effect compared to Type II and Type III strains. 
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INTRODUCTION 
Innate immunity is critical in the immune system for sensing and reacting to microbial 
infection. Toll like receptors (TLRs) play an essential role in recognizing the 
pathogen-associated molecular patterns (PAMPs) (1). TLRs have evolved into more 
than thirteen individual receptors to recognize a variety of pathogen molecules. As of 
today, a total of eleven TLRs have been identified within human beings and thirteen in 
mice, recognizing bacterial products like LPS, virus components such as ssRNA, 
DNA, and proteins such as bacterial flagellin (2). 
 
Most TLRs depend on an important adapter protein, MyD88, for their signal 
transduction. However, TLR3 is an exception in that its signaling transduction does 
not involve MyD88. TLR4 has also been shown to trigger both MyD88 dependent and 
independent pathways upon ligand binding. Specifically, the MyD88 dependent TLR4 
pathway leads to the activation of mitogen-activated protein kinase (MAPK) and 
NFκB pathways, initiating inflammatory cytokine production. MyD88 independent 
TLR4 and TLR3 pathways signal through TIR-domain-containing adapter-inducing 
interferon-β (TRIF), which leads to activation of the transcription factor IRF3 and 
induces IFN-inducible genes and IFN-β (3).  
 
Previously, our laboratory has shown that T. gondii actively interferes with 
macrophage function during intracellular infection. Specifically, the parasite is able to 
inhibit LPS-triggered TLR4 signaling leading to IL-12 and TNFα production. The 
infected cells are not responsive to LPS stimulation and TLR4 signal transduction is 
impaired (4, 5). We were therefore interested in investigating whether T. gondii 
infection has any effects on signaling pathways triggered by other TLR ligands. We 
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were especially interested in understanding the influence of parasite infection on TLR 
signaling that involves MyD88 independent pathways. 
There is evidence that T. gondii preferentially uses cells of innate immunity, especially 
macrophages and DCs, as reservoirs of infection and early dissemination (6-9). 
Therefore we were interested in expanding our studies to examine the effects of 
parasite infection on dendritic cell (DC) signaling. Furthermore, previous studies 
indicated strain specific differences in parasite induced IL-12 responses (10). 
Therefore, we also wanted to compare parasite strain types I, II and III in terms of 
interference in DC signaling.  
 
Previously (Chapter 2 and Chapter 3), we established that the T. gondii RH strain 
inhibits global phosphorylation of histone H3 at Ser10
 
 in macrophages induced by LPS 
and/or immune complex and LPS. In this study, we wanted to examine whether other 
parasites, in particular Type II and Type III strains, have the similar effects on global 
phosphorylation of histone H3.  
In this study, we found that T. gondii inhibits the IL-12 response triggered by all tested 
TLR ligands. Moreover, by using MyD88 knockout mice, we found that both MyD88 
dependent and independent signaling in macrophages is inhibited by the parasite, as 
Type I interferon production triggered by either TLR3 ligand Poly IC or TLR4 ligand 
LPS is blocked by infection. We also found that in DCs, LPS induced TNF responses 
are inhibited by Type I RH strain infection, but not by Type II or Type III strains. In 
addition, the Type I RH strain displays the most potent inhibitory effect on LPS 
induced global phosphorylation of histone H3 at Ser10
 
.  
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 MATERIAL AND METHODS 
Mice and parasites
C57BL/6 female mice (6–8 wk of age) were purchased from
  
 The Jackson Laboratory. 
TLR2/4 knock out mice were provided by Dr. David Russell (Cornell University). The 
mice were kept under specific pathogen-free conditions at the Transgenic Mouse 
Facility, Cornell University College of Veterinary Medicine. The facility is overseen 
by an Institutional Animal Care and Use Committee. T. gondii parasite strains RH, 
PTG and VEG were maintained by biweekly passage on human foreskin fibroblast 
monolayers in DMEM supplemented with 1% FCS, 100 U/ml penicillin, and 0.1 
mg/ml streptomycin. In some experiments, we used transgenic RH strain 
tachyzoites expressing tandem copies of the gene encoding yellow fluorescent protein 
(provided by D. Roos, University of Pennsylvania, Philadelphia, PA, and B. Striepen, 
University of Georgia, Athens, GA). Parasite cultures were tested for Mycoplasma 
every 6–8 wk using a highly sensitive PCR-based ELISA (Roche Diagnostics).
 
  
Cell culture
Bone marrow cells were flushed from femur and tibia and cultured
  
 in complete 
DMEM consisting of DMEM supplemented with 10% FCS, 1 mM sodium pyruvate, 
0.1 mM nonessential amino acids, 20% supernatant from L929 cells, 100 U/ml 
penicillin, and 0.1 mg/ml streptomycin. The cells were supplemented with fresh 
macrophage medium on day 3. After 5 days of culture, nonadherent cells were 
removed, adherent monolayers were washed in ice-cold PBS, and cells were harvested 
by gentle pipetting in DMEM supplemented with 1% FCS, 100 U/ml penicillin, and 
0.1 mg/ml streptomycin. Infection of macrophages was accomplished by adding 
tachyzoites to cell cultures followed by brief centrifugation (200 x g for 3 min) to 
synchronize contact between cells and parasites. In most cases, toll like receptor 
99 
 
ligands were added 12 h after infection. Cells were recovered at varying times as 
indicated, depending upon the assay performed. Dendritic cells were derived from 
bone marrow by flushing from femur and tibia and cultured 
 
in complete DC low 
medium consisting of RPMI supplemented with 10% FCS, 0.1% of 50uM 2-βME, 
20ng/ml GM-CSF and 100 U/ml penicillin, and 0.1 mg/ml streptomycin. On day 3, the 
cells were fed with 9ml per plate of DC low 2- βME medium containing GM-CSF. On 
day 6, the cells were fed with 7-8ml of DC high 2- βME medium containing GM-CSF. 
On day 8, GM-CSF was directly added into the medium. Dendritic cells were 
collected on day 9 and infected as mentioned above.  
Reagents 
Toll like receptors ligands were purchased from Invitrogen and used according to the 
manufacturer’s instructions (Mouse TLR1-9 Agonist kit).  
 
Cytokine ELISA
IL-10 in cell culture supernatants was measured using commercial
  
 kits according to 
the manufacturer’s recommendations (R&D 
 
Systems). Interferon beta in cell culture 
supernatants was measured by an ELISA based assay developed by Dr. Melissa 
Lodoen from Stanford University. 
 
RT-PCR 
RNA was extracted from the cell samples by a Invitrogen RNA mineasy Kit and then 
reverse transcribed into cDNA as PCR templates. The PCR was performed as 
described in Chapter 2.  
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Immunoblotting 
The following antibodies were employed in immunoblotting studies: anti-phospho-
histone H3 (Ser10) (cat. # 9701, Cell Signaling), anti-tri-methyl-histone H3 (Lys4) (cat. 
# 9751, Cell Signaling), anti-mono-methyl-histone H3(Lys4) (cat. # 9723, Cell 
Signaling), anti-acetyl-histone H4 (Lys8) (cat. #2594, Cell Signaling) anti-total H3 (cat. 
# 9715, Cell Signaling). Cells (2 x 106/sample) were lysed in reducing SDS sample 
buffer, and DNA was sheared by forcing samples 5 times through a 27-gauge 
needle. In some experiments, nuclear and cytoplasmic portions of cell lysates were 
separated by using a nuclear extract kit (Active Motif). After 5 min at 100ºC, samples 
were separated by 10% SDS-PAGE, and proteins were subsequently 
electrotransferred onto nitrocellulose membranes. Membranes were then blocked in 5% 
nonfat dry milk containing 0.1% Tween 20 in Tris-buffered saline, pH 7.6 (TBST), for 
1 hr at room temperature, followed by incubation with antibody reconstituted in 5% 
BSA in TBST overnight at 4°C. After washing blots in TBST, primary antibodies were 
detected with a horseradish peroxidase-conjugated secondary antibody in TBST 
containing 5% nonfat dry milk for 1 h at room temperature. 
 
After washing in TBST, 
protein bands were visualized using a chemiluminescence based detection system 
(Cell Signaling). 
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RESULTS 
T. gondii inhibits IL-12 responses induced by a diverse array of TLR ligands. 
Our previous studies show that Toxoplasma infection blocks LPS induced TNFα and 
IL-12p40 responses triggered through TLR4. We wanted to test whether the response 
to other TLR ligands was also suppressed. We first determined the optimal 
concentration for each individual TLR ligand to stimulate macrophages by serial 
titration (data not shown). Then we used the Toxoplasma Type I RH strain to infect 
the macrophages and then subjected these cells to stimulation with each TLR ligand. 
We found that TLR3 and TLR5 ligands induced moderate IL-12 production, while all 
other TLR ligands induced higher amounts of IL-12p40. However, infected 
macrophages were unable to upregulate IL-12 in response to stimulation with each of 
these TLR ligands (Figure 4.1). To rule out the possibility of endotoxin contamination 
in the preparations of TLR ligands, we used macrophages derived from TLR2/4 
double knock out mice and found that the IL-12 responses we observed could not be 
attributed to contamination by endotoxin or bacterial lipids that engage TLR2 and 
TLR4 (Figure 4.2).     
 
T. gondii inhibits MyD88 independent signaling pathways 
Since TLR3 signals through an MyD88 independent pathway to induce Type I 
interferon, we next examined whether T. gondii could block this response. Poly IC 
was used as a TLR3 ligand to stimulate macrophages. By RT-PCR, we found that Poly 
IC induced IFN- β upregulation was inhibited by Toxoplasma. We also found that 
Poly IC induced IL-12 mRNA was blocked by the infection (Figure 4.3.A). We used 
ELISA to examine the protein level of IFN-beta and found similar results where T. 
gondii blocked the Poly IC induced IFN-beta response even at a low parasite to cell  
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Figure 4.1 T. gondii inhibits IL-12 responses induced by all tested TLR ligands. 
Macrophages were infected with the T. gondii RH strain at the indicated parasite to 
cell ratio for 2 hr. The cells were then either treated with (black bar) or without (white 
bar) with the indicated TLR ligands. The optimal TLR ligand concentrations were 
previously determined by titration on macrophages. Supernatants were collected 6 hr 
later and subject to ELISA to measure the IL-12 p40 concentrations. Y, IL-12 p40 
(pg/ml); X, parasite to cell ratio. 
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Figure 4.2 IL-12 responses induced by various TLR ligands are not due to 
contamination with bacterial ligands for TLR2 and TLR4. Macrophages from 
either WT or TLR2/4 double knock out mice were treated with indicated TLR ligands. 
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6 hr later, supernatants were collected and subjected to cytokine ELISA to determine 
the IL-12 p40 concentrations.  
ratio  (1.5:1). We used macrophages from MyD88-/-
 
 mice to confirm that the responses 
were MyD88 independent (Figure 4.3.B). 
T. gondii Type I RH strain inhibits TNFα triggered by LPS in dendritic cells. 
Previously we found that LPS induced TNFα in macrophages is blocked by T. gondii 
RH strain. In this experiment, we wanted to examine the effect of parasite infection on 
the LPS induced TNFα  response in dendritic cells, as well as whether there were the 
differences between three parasite strains. Here, we used T. gondii Type I RH strain, 
Type II PTG strain and Type III VEG strain to infect bone marrow derived dendritic 
cells. When uninfected DCs were stimulated with LPS, these cells produced high 
amounts of TNFα. We observed that RH strain blocked TNF response, but PTG and 
VEG did not have inhibitory effects (Figure 4.4), even though all three parasite strains 
infected the cells at similar rates. 
 
Toxoplasma Type I RH strain inhibits global phosphorylation of histone H3 at Ser10
Previously we established that the Toxoplasma RH strain blocked global 
phosphorylation of histone H3 at Ser
 
induced by LPS more strongly than PTG and VEG strains. 
10. This corresponded to the parasite’s ability to 
decrease histone modifications on TNFα and IL-10 promoters. Therefore, we were 
interested to know whether Type II and Type III parasite strains have similar effects 
on global phosphorylation of histone H3. In this experiment, we observed that Type I 
RH strain potently inhibited phosphorylation of histone H3 at Ser10 triggered by LPS. 
Type II PTG strain also blocked phosphorylation of histone H3 at Ser10, but not as 
strong by the RH strain. Type III VEG strain did not seem to have any inhibitory 
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effect on pH3S10 (Fig 4.5). We also performed immunofluorescence staining on 
infected macrophages and observed similar effects (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 T. gondii inhibits MyD88 independent type I interferon response. In A, 
Macrophages from MyD88+/+ and MyD88-/- mice were infected with RH at a parasite 
to cell ratio of 3:1 for 18 hr. The cells were then subjected to LPS stimulation (100 
ng/ml) for 30 mins. RNA was extracted from the cells and reversed transcribed into 
cDNA. PCR was performed to examine the expression of IFNβ and IL-12 p40. 
GAPDH was used as an internal control for PCR reactions. In B, macrophages were 
treated similarly and then supernatants were collected and cytokine ELISA was 
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performed to determine the IFNβ concentration. M, medium; P, Poly IC stimulated; R, 
RH infected; R+P, RH infected plus Poly IC stimulated.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 RH but not PTG or VEG inhibits TNFα response in dendritic cells. 
DCs were infected with RH, PTG and VEG at indicated parasite to cell ratio for 2 hr. 
The cells were then subjected to LPS stimulation (100 ng/ml). Supernatants were 
collected 6 hr later and cytokine ELISA was performed to determine the TNFα 
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concentration. The infected cell percentages in this experiment were calculated as: RH 
45%, PTG 40%, VEG 38% (3:1).  
Effect of T. gondii infection on other histone modifications.  
The ability of the T. gondii RH strain to inhibit phosphorylation of histone H3 at Ser10 
prompted us to examine other histone modifications. In this study, we performed 
Western blotting on cell lysates of bone marrow-derived macrophages using 
antibodies against other histone modifications including acetylated histone H4 at Lys8, 
mono-methylated histone H3 at Lys4 and tri-methylated histone H3 at Lys4
 
. We 
consistently observed that unstimulated cells contained these modifications and we 
could not detect any difference between LPS treated and non-treated cells, nor did we 
observe any effect from parasite infection (Figure 4.6).  
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Figure 4.5 Effect of different parasite strains on global phosphorylation of 
histone H3 at Ser10 induced by LPS. Macrophages were infected with T. gondii RH, 
PTG and VEG strains at a parasite to cell ratio of 3:1 for 18 hr. The cells were then 
treated with LPS at 100 ng/ml for the indicated time periods (mins). The cells were 
lysed and Western blotting was performed to examine the level of phosphorylated H3 
at Ser10
 
. Total H3 was blotted for controlling equal protein loading. In this experiment, 
the infected cell percentages were calculated as: RH 92%, PTG 86%, VEG 87%. 
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Figure 4.6 Effect of T. gondii infection on additional histone modifications. 
Macrophages were infected with the T. gondii RH strain at a parasite to cell ratio of 
3:1 for 18 hr. The cells were then treated with LPS at 100 ng/ml for the indicated time 
periods (mins). Cell lysates were collected and Western blotting was performed to 
examine the levels of acetylated histone H4 at Lys8, mono-methylated histone H3 at 
Lys4 and tri-methylated histone H3 at Lys4
 
. Med, medium; Tg, T. gondii. 
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DISCUSSION 
As one essential component of innate immunity, Toll like receptors (TLRs) as well as 
their downstream signaling pathways are widely studied. Most TLRs use MyD88 as 
their adapter protein while TLR3 signaling is MyD88 independent, and requires an 
alternate adapter molecule called TRIF. TLR4 is a unique receptor because it uses 
both MyD88 dependent and independent pathways (11).  
 
The intracellular protozoan parasite T. gondii has been previously found to inhibit 
TLR4 signaling and shut down the LPS- induced TNFα and IL-12 responses (4, 12). 
In this study, we found that T. gondii infection blocks all TLR ligand induced IL-12 
responses. Moreover, the parasite inhibited Type I interferon responses stimulated by 
Poly IC, a TLR3 ligand. The parasite therefore seems to have a universal inhibitory 
effect on all TLR signaling pathways, including those that do not involve MyD88. T. 
gondii shuts down IL-12 responses possibly for its intracellular survival because IL-12 
is essential in mounting an efficient immune response to clear the infection (13).  
 
Toxoplasma itself contains pathogen-associated molecular patterns (PAMPs) that can 
be recognized by TLRs. The parasite glycosylphosphatidylinositol (GPI) moieties are 
recognized by TLR2 and TLR4 (14, 15). T. gondii profilin was also found to be a 
TLR11 ligand, even though humans do not have a functional TLR11 (16-18). The 
inhibition of TLR signaling can therefore be speculated to be necessary for the parasite 
to evade immune responses triggered by host recognition of its own molecules.   
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Previous gene microarray studies performed in our lab show that T. gondii does not 
inhibit every gene induced by LPS in macrophages (19). For example, the parasite 
does not inhibit the IL-10, CCL2 and TGFβ induced by LPS. Since we only looked at 
IL-12 induction in this study, it is reasonable to speculate that the infection does not 
shut down all genes induced by each TLR signaling. Future studies focusing on 
individual TLR are required to validate this speculation. 
 
We also observed that in dendritic cells, the LPS-induced TNFα response is inhibited 
by T. gondii Type I RH strain, but not by Type II PTG or Type III VEG strains. Also, 
the Type I RH strain most potently inhibited LPS triggered global phosphorylation of 
histone H3 at ser10
 
. This is interesting because Type I strains are generally more 
virulent and have faster replication/dissemination rate compared to the other two 
strains. It is possible that the Type I strain is more capable of interfering with host 
signaling (20, 21).  
We examined the influence of T. gondii infection on other histone modifications  such 
as acetylated histone H4 at Lys8, mono-methylated histone H3 at Lys4 and tri-
methylated histone H3 at Lys4. 
 
Unfortunately, we were unable to draw conclusions 
from our data because unstimulated cells already carried those histone modifications. 
With the complexity of the histone code, it remains possible that T. gondii influences 
other histone modifications that we did not examine here.   
We have been working on the exact molecular mechanism by which T. gondii blocks 
LPS induced global phosphorylation of histone H3 at Ser10. In this study, we 
examined two upstream kinases that are responsible for phosphorylation of histone H3 
at Ser10, MSK-1 and MSK-2 (22, 23). However, we could not detect any effect by the 
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parasite on the activation of MSK-1(Figure 2.6, Chapter 2) and antibodies to MSK-2 
proved to be ineffective (data not shown). It is possible that the parasite uses its own 
effector molecule, for example a parasite phosphatase, to fulfill this inhibition or 
possibly the parasite could utilize its own kinase to activate a host phosphatase. With 
the recent identification of parasite effectors being injected into the host nucleus, the 
kinase ROP16 and the phosphatase PP2C-hn, we hope to identify the relevant 
molecules in the future (24-26). 
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CHAPTER FIVE 
 
Discussion* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This Chapter is based in part on the manuscript “Dysregulation of macrophage signal 
transduction by Toxoplasma gondii: past progress and recent advances” by J. Leng, B. 
A. Butcher & E. Y. Denkers. Parasite Immunology, in press. 
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1. Summary of Findings 
As one of the most successful parasites that infects around 20-50% of human 
population, Toxoplasma gondii is a master at manipulating host cell functions to 
enable its survival, replication and transmission. During in vivo infection, a  reservoir 
of infection are cells of innate immunity, particularly macrophages and dendritic cells 
(1-5). This thesis focused on the manipulation of macrophage functions by T. gondii.  
 
In Chapter 2 and 3, the role of T. gondii infection on host cell chromatin remodeling 
was investigated on both the TNFα and IL-10 promoter. I found that T. gondii is able 
to block the phosphorylation of histone H3 at Ser10 and acetylation of histone H3 at 
Lys9/Lys14
 
 at both proximal and distal regions of TNF promoter. Therefore, even 
though transcripition factors like NFκB are normally activated and translocated into 
the nucleus, they are not able to bind to the promoter region to start the transcription. 
Similar results were found on the IL-10 locus when the macrophages were activated in 
the presence of immune complex.  
In Chapter 4, I found that T. gondii infection blocked IL-12 induction by virtually all 
tested TLR ligands. Furthermore, the MyD88 independent Type I interferon 
production triggered by TLR3 ligand Poly IC, and TLR4 ligand LPS, was also 
inhibited by the parasite. I also for the first time examined suppression in dendritic 
cells (DCs). I obtained evidence that Type I but not Type II and Type III parasites 
blocked TNFα responses induced by LPS. Strain comparison studies also showed that 
Type I parasites most potently inhibited LPS induced global phosphorylation of 
histone H3 at Ser10
 
 in macrophages.    
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2. Inhibition of Toll-like receptor signaling by T. gondii 
After invasion of macrophages, Toxoplasma actively down-regulates a large panel of 
pro-inflammatory cytokines and chemokines that are normally induced by TLR 
signaling (6, 7). We observed in particular that LPS-triggered IL-12p40 and TNFα are 
suppressed in infected cells. While the parasite itself eventually initiates IL-12 
synthesis, TLR4-triggered production of TNFα remains potently suppressed. The 
ability of T. gondii to block LPS triggered responses requires active invasion. Thus, 
heat inactivated tachyzoites do not display suppressive activity, and when parasite 
entry is prevented by cytochalasin D blockade of actin polymerization, suppressive 
activity is also lost (8). The suppressive activity of Toxoplasma on LPS-induced TNFα 
requires parasite survival within the host cell. This is evidenced by the fact that drug 
induced tachyzoite inactivation after invasion restores the ability of cells to respond to 
TLR4 triggering. We also recently found that signalling through other TLRs is 
blocked during infection. Importantly, this includes TLR3, an intracellular receptor for 
double-stranded RNA that, unlike other TLR, signals in a manner independent of 
MyD88. Suppression of TLR signalling does not appear to be restricted to RH strain 
tachyzoites because other Type I, as well as Type II strain parasites also blocks LPS 
induction of TNFα in macrophages (9).  
 
The block in TLR signalling has also been reported to occur in bone marrow-derived 
DCs (10). In this case, infected immature DCs fail to mature in response to LPS 
triggering, and the cells were deficient in their ability to activate T cells. During in 
vivo infection, we also obtained evidence that Toxoplasma blocks cytokine production 
in infected cells. Infected macrophages collected from the peritoneal cavity following 
i.p. parasite inoculation are suppressed in their ability to produce TNFα, and infected 
DCs in the spleen are defective in IL-12 production (1, 9). Thus, suppression of TLR 
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signalling by T. gondii appears to be a general phenomenon that occurs in several cell 
types.  
 
Deactivation of TLR signalling by Toxoplasma may indicate the need for the parasite 
to avoid triggering these pathways by the parasite’s own TLR ligands. Thus, the 
Toxoplasma profilin molecule TGPRF activates TLR11 and parasite 
glycosylphosphoinositol (GPI) moieties associated with tachyzoite surface proteins 
possess the ability to activate TLR2 and TLR4 (11, 12). As both profilin and GPI 
synthesis are essential for survival, the parasite may be under evolutionary pressure to 
block TLR signalling during intracellular infection. In this regard, the 
immunodominant CD4+
 
 T-cell response to TGPRF characterized by Yarovinsky et al. 
might result from recognition of this TLR11 ligand by noninfected antigen presenting 
cells. It is also possible that blocking TLR signalling is a means to prevent 
proinflammatory responses that would otherwise be triggered by exposure to gut flora 
now known to occur during oral T. gondii infection (13, 14). Another possibility is 
that inability to respond to TLR ligands reflects a general nonresponsiveness of cells 
to proinflammatory signals no matter what the initiating stimulus, rather than being 
specific for TLR pathways. 
There is evidence that other protozoans target NFκB and MAPK pathways. For 
example, data suggest that Leishmania down-regulates proinflammatory signaling 
through induction of SHP1, a phosphatase that plays a role in deactivation key 
components of both Jak ⁄ Stat and TLR pathways (15, 16). Recently, it has been 
reported that Leishmania proteases cleave kinases involved in p38 MAPK and NFκB 
activation (17, 18). Infection with T. cruzi is also reported to induce macrophage TLR 
nonresponsiveness through induction of host cell phosphatase activity (19). Taken 
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together, while it is clear that infection with Toxoplasma and other protozoans 
interferes with the ability to respond to TLR ligands, there is not yet a definitive 
picture of how this is accomplished in any case. 
 
3. Interference with host chromatin remodeling by T. gondii 
Inducible gene expression is now understood to involve two types of regulatory 
cascades. One type of transduction cascade leads to transcription factor activation, 
most often involving kinase signalling, to enable binding to target DNA sites on gene 
promoters. The particular pattern of transcription factors activated plays a role in 
determining the specificity of genes induced. At the same time, it is now appreciated 
that chromatin structure itself is subject to regulation, inasmuch as signalling leading 
to covalent modification of histones plays a role in determining the activity of 
transcription factors (20).  
 
Toxoplasma suppresses TNFα production in bone marrow-derived macrophages, and 
this is associated with decreased recruitment of RNA polymerase II to the promoter 
(9). This finding links suppression of TNFα release to decreased transcription rather 
than downstream effects such as diminished mRNA stability, altered RNA splicing or 
decreased translation. In a close examination of the TNF promoter during TLR4 
stimulation of T. gondii -infected macrophages, we concluded that the parasite targets 
chromatin modification rather than transcription factor activation (9). In 12 hr infected 
macrophages, subsequent LPS-triggered NFκB nuclear translocation was unaffected 
by the parasite. In addition, activation and nuclear translocation of c-Jun and CREB, 
two other TNF-associated transcription factors, appeared largely normal in infected 
cells. However, NFκB as well as c-Jun and CREB were unable to bind to the TNF 
promoter. This is explained by the ability of the parasite to inhibit 
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Ser10 phosphorylation and Lys9/Lys14
 
 acetylation of histone H3 at the TNF promoter, 
modifications associated with increased transcriptional activity (21). Thus, evidence 
indicates that chromatin structure surrounding the TNF promoter remains in a closed 
state in infected cells, and the transcription factors therefore cannot gain access to their 
binding sites. In turn, RNA polymerase II is not recruited to the TNF promoter and 
transcription is not initiated (9). Because Toxoplasma does not affect low level IL-10 
production triggered by TLR4, we examined histone H3 modification at the promoter 
for the gene encoding IL-10. In this case, LPS itself did not induce histone H3 
modification, and the parasite therefore had no effect at the promoter for IL-10. Yet, 
when IL-10 was super-induced with the combination of immune complex and LPS (22, 
23), histone H3 phosphorylation and acetylation occurred, and Toxoplasma 
simultaneously blocked chromatin modification and high level IL-10 production.  
Given these results, it is tempting to speculate that targeting chromatin modification in 
the host cell provides an explanation for the ability of Toxoplasma to simultaneously 
down-regulate a large panel of proinflammatory genes (7). Rather than targeting 
specific transcription factors (which conceptually would seem to be a relatively 
inefficient way to shut down multiple genes), the parasite may achieve the same effect 
by blocking inducible modification of H3 and possibly other histone molecule. Such 
an inhibitory mechanism would also account for the ability of Toxoplasma to down-
modulate signaling though all TLR..  
 
How Toxoplasma influences host histone modification is unclear, but the host cell 
nucleus is emerging as a target for parasite effector proteins. Whether the putative 
kinase ROP16 or the phosphatase PPC2-hn, parasite proteins that traffick to the host 
cell nucleus (24, 25), influence histone modification either directly or indirectly 
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remains to be determined. It is also possible that other parasite kinases or phosphatases 
may be delivered into the host nucleus to actively interfere with host gene 
transcription by targeting chromatin remodelling. 
 
While Toxoplasma is the only intracellular protozoan identified to date that is capable 
of interfering with host cell chromatin modification, it is possible that other parasitic 
protozoans possess similar properties. In this regard, a growing number of bacterial 
pathogens have recently been reported to interfere with host chromatin remodeling 
required for gene expression (26). Shigella flexneri injects OspF, a dually specific 
serine–threonine phosphatase, into epithelial cells followed by relocalization of the 
protein to the host nucleus (27). Here, OspF blocks histone H3 Ser10
 
 phosphorylation, 
thereby preventing induction of a subset of NFκB-responsive genes including IL-8. 
The OspF molecule appears to act by dephosphorylating ERK and p38, MAPK that lie 
upstream of histone H3 phosphorylation. Studies with OspF null Shigella suggest that 
lack of this protein results in early IL-8-dependent neutrophil recruitment in vivo, 
resulting in attenuation of infection (27).  
Listeria monocytogenes, another well-known bacterial pathogen, was also recently 
found to dephosphorylate histone H3 on Ser10 and deacetylate histone H4 during early 
infection (28). This relates to a decreased level of transcription of a subset of host 
genes, including several key immune-related genes. The Listeria virulence factor, 
listeriolysin O, was identified as the major protein required for dephosphorylation of 
histone H3 and deacetylation of histone H4. Interestingly, other toxins of the same 
family such as Clostridium perfringens perfringolysin and Streptococcus pneumoniae 
pneumolysin have also been found to dephosphorylate histone H3 at Ser10
 
. 
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Other evidence for pathogen interference with chromatin structure comes from studies 
on Mycobacterium tuberculosis. This opportunistic pathogen inhibits IFN-γ-induced 
MHC class II gene expression by upregulating histone deacetylation at the HLA-DR 
promoter region in human THP-1 monocyte ⁄macrophage cells. The activity is 
mediated by increased expression of Sin3A, a corepressor required for MHC class II 
repression by histone deacetylase (29). A related study showed that a 19-kDa 
lipoprotein from mycobacteria, LpaH, inhibited acetylation of histone H3 and H4 at 
the CIITA promoter. LpaH also blocked recruitment of Brahma-related gene 1, a 
chromatin remodelling protein, to the promoter (30). The effect of LpaH is believed to 
be mediated through TLR2-induced p38 or ERK MAPK signalling. 
 
More recently, a virus protein encoded by white spot syndrome virus, ICP11, has been 
identified as a histone-binding DNA mimic that disrupts host cell nucleosome 
assembly (31). ICP11 is believed to compete with host DNA for histone proteins, in 
particular the H2A variant H2A.x, which functions in repairing DNA double-strand 
breaks. Host cell chromatin is therefore vulnerable to DNA damage, leading to 
disruption of the nuclear transcription machinery. This may facilitate the host cell 
death caused by infection, promoting transmission of the virus. 
 
Based upon these examples and our findings in Toxoplasma, there are strong 
suggestions that the host cell chromatin modification machinery represents an 
Achille’s heel for pathogen exploitation. Interfering with inducible histone 
modification potentially allows the pathogen to simultaneously down-modulate a large 
panel of host genes using a common mechanism. We do not yet know precisely how 
Toxoplasma – and possibly other intracellular protozoans – achieve this aim. However, 
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studies with bacterial and viral pathogens may provide us with clues as to how T. 
gondii interferes with host chromatin modification during intracellular infection. 
 
4. Final conclusions and future directions 
The manipulation of the host cell by T. gondii has been widely studied and appreciated 
in recent years. The findings in my thesis provide more details in how Toxoplasma 
interferes with host signaling. Toxoplasma has been shown in these studies to target 
chromatin remodeling to inhibit TNFα and IL-10 transcription. It is possible that the 
parasite utilizes this strategy to inhibit cytokine gene transcription for its own benefits. 
 
In this regard, we would like to propose the following mechanisms by which T. gondii 
inhibits a large panel of inflammatory cytokines: during invasion and formation of PV, 
the parasite injects kinases and phophatases into host nucleus and these molecules 
either act directly (dephophorylate histone) or indirectly (phophorylate some host 
phosphatase to fulfill the same functions) on the host chromatin. The chromatin 
structures surrounding gene promoters therefore remains in a condensed state and 
transcription machinery cannot obtain access to these promoters.  
 
In the future, there are still questions to be answered. First, as mentioned above, we do 
not know yet how exactly the parasite manages to interfere with host chromatin 
remodeling. Specifically, we do not know if the parasite is producing a molecule to 
fulfill this function or if the parasite is hijacking a host molecule to accomplish this. 
With the discovery of more and more parasite molecules that are delivered into the 
host cell, we can expect to solve this question in the future. Second, we know that 
Toxoplasma does not inhibit every cytokine during infection, so an obvious question is 
that whether the interference with host chromatin remodeling is restricted to specific 
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gene clusters on the chromosome. It would then be interesting to study the relationship 
between T. gondii suppressed genes and T. gondii enhanced genes. Future studies will 
be required to address these important questions.  
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